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ABSTRACT
The protein requirement of synapses poses a unique problem
as they are located at some distance from the cell body.

The

macromolecular requirement of synapses is a problem by itself
in normal state, as well as in pathological conditions.

The

question arises as to whether synapses synthesize all their
proteins or do they depend on the cell body for proteins.
As a model to study such a mechanism, we chose a system of
isolated synaptosomes and microsomes from 20 and 58 .day :.:at
brain previously injected with DFP and studied specifically
the synthesis of ACbE.

47%

of

In 20 day old rats, following DFP,

the inhibited AChE was synthesized at nerve endings,

while for the same period 112% of the inhibited enzyme was
synthesized at microsomes.

Since this period represents a

period of rapid growth in the animal, attempts were made to
differentiate the enzyme arising due to nom.al growth and
those arising due to enzyme replacement after DFP inhibition.
After the appropriate corrections, it was found that AChE
synthesized to replace the DFP inhibited enzyme a.mounted to

43%

at the nerve endings and to 16% at the microsomes.

In

58 day old rats, 64% of the inhibited nerve ending AChE was
synthesized and for the same period microsomes synthesized

45%

of the inhibited enzyme.

This phenomenon was not an age

dependent one as it was found in both age groups.

ACbE was

found to be synthesized at nerve endings without a concomittant

increase or decrease of microsomal enzyme which suggested an
independent synthesizing machinery of nerve endings.

When

Triton X-100 was used to solubilize AChE, the inhibition due
to DFP was considerably less in nerve terminals and microsomes
compared to DFP inhibition measured in buffer treated fractions.
These results suggest that a reservoir of the enzyme is not
available to substrate and to inhibitors such as DFP.

We also found differences in the rate of inhibition and
recovery of isoenzymes in the rrlicrosomal and nerve ending
fraction following DFP which further confirmed the independent
synthesizing machinery of the nerve endings.

On the day of

injection:, the order of inhibition of the 4 microsomal isoenzymes was 81, 49, 25 and 03 for isoenzymes 4,3,2,1.

Fifteen

days following DFP, the inhibition of isoenzyme 4 was 363 and
isoenzyme 2 was 253.

In the same period, inhibited isoenzyme

3 was completely replaced by newly :. synthesized AChE.

The in-

hibition and recovery of nerve ending isoenzyme were also studied
in a manner similar to those of the rrlicrosomal isoenzymes.

On

the day of injection, the isoenzymes 4,3,2 and 1 were inhibited

83, 30, 4 and 82% respectively.

Fifteen days following DFP

injection, the inhibition of isoenzyme 4 and 1 was 16 and 25
percent respectively.

Inhibited isoenzyme 3 and 2 were com-

pletely replaced by newly synthesized enzyme.

The isoenzymes

of nerve ending demonstrated different order of sensitivity to
DFP and of the recovery rate indicating a different turnover rate.

Certain hypothesis were made regarding the function of
these isoenzymes.

Microsomes might supply the enzyme around

the cell body which prevents the proliferation of Ach into
cell from other sources.

Nerve endings might supply the

enzyme at the junctional complex whose main role is to hydrolyze the transmitter following · chemical transmission.
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INTRODUCTION
BACKGROUND
The studies of the ultrastructure of the CNS demonstrated
that the central nervous system is a highly organized assembly
of cells as originally postulated by His (1886), and not a
continuous syncytium as originally suggested by the reticularists (Golgi, 1907).

Two types of cells are found:

the

neurons or nerve cells and the neuroglia or supporting cells.
Although both types of cells maintain the architecture of
nervous system, the transmission and integration of information
relayed by the nerve impulses are the unique function of neurons,

STRUCTURE OF THE NEURON AND OF SYNAPSES
The neuron is a complete anatomical unit composed of a
nucleus, cytoplasm and a surrounding membrane which protects
the cell constituents and forms a boundary with respect to
other elements in the nervous tissue.

Varieties of neurons

may be differentiated on the basis of the differences in
size, shape, distribution and on the number and spread of
their processes.

The typical neuron has a soma, a series of

processes called dendrites, and an axon.

Dendrites originate

at the soma and distribute in all directions; the axons stem
from the soma or from a large dendrite and terminate at varying distances in contact with other nerve cells, muscle
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fibers or with gland cells.

In the vertebrates, neurons can be monopolar, bipolar
or multipolar, depending upon the pattern and characteristics
of their processes.

Most neurons have a large number of den-

drites emerging from cell body and for this reason are said
to be multipolar.

When a single process arises from cell

body, the neuron in question is monopolar; when two processes
arise from cell body, the pertinent neurons are bipolar.

In

mammals the diameter of the neuronal soma varies from few
microns, as in the case of granular cells in cerebellar
cortex, to close to a tenth of a millimeter for the large
vestibular cells of the medulla oblongata and the motor
neurons in the anterior horn of the spinal cord.

Dendrites are extensions of the perikaryon of a
neuron.

They contain the same organelles as the perikaryon

and are never ensheathed by myelin.

Axons on the other

hand may or may not be ensheathed bymyelin.

Microtubules

are the most prominent elements in the cytoplasm of large
dendrites arising from multipolar cells,

Other cytoplasmic

organelles are neurofilaments, endoplasmic reticulum, mi to-chondria, golgi apparatus, vesicles and multivesicular
bodies,

A granular endoplasmic reticulum shows .distribu--

3
tion similar to that of perikaryon.

In axon, few ribosomes

are present in the initial segment, but they do not extend
beyond it.

The remainder of the axon .is devoid of ribosomes,

but it contains mitochondria, neurofilaments and multivesicu-lar bodies; it is characterised by absence of two components
that are present elsewhere, granular endoplasm5c reticulum
and free ribosomes.

The morphology of the neuronal tontacts is consistent
with Ramon y Cajal's neuron theory; this theory states in
effect that the transmission of nerve impulses from one
cell to another is mediated through functional contacts
specialized for transmission, which were defined originally
by Sherrington (1897) as synapses,

Electron microscopy and

SQbcellular neurochemistry has enormously advanced our
knowledge of synapses in the central nervous system; the
pertinent studies were particularly advanced by three
modern investigators and their associates:

De Robertis

(1958, 1959), Palay (1958) and Whittaker (with Gray, 1962),
As can also be seen in our ovm microphotographs (cf. Results),
the presynaptic fiber ends in an expanded terminal, the
synaptic knob which is intimately associated with a portion
of the membrane of

th~

postsynaptic neuron,

The subsynaptic

membrane is separated from the synaptic knob by a.very
narrow and remarkably uniform space, the synaptic cleft.

p
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The synaptic knob contains several mitochondria and, most
characteristically, large number of.synaptic vesicles, 300
to 6oO

•A

in diameter.

Synaptic vesicles were independently

recognized by two early investigators who employed

electron~

microscopy (De Robertis and Bennett 1954, 1955; Palade and
Palay, 1954); the synaptic vesicles are of particular significance because there is much evidence that they contain
preformed packets of the transmitter.

FUNCTION OF THE NEURON
In the brain, transmission across relatively significant distances is carried by axons; this t:ype of transmission may be referred as conduction or propagation of
nerve impulses which occurs in an all or none fashion ..
The axons are specialized for conducting information from
one place to another.

The impulse discharged travels

along the various branches (10 to hundreds) of an axon,
to activate synapses thereon.

According to the principle

of convergence, neurons receive synapses from many neurons;
these synapses can be excitatory or inhibitory.

The synapses

are the locus of the so-called synaptic transmission.

The

number of synapses at a neuron vary, the highest recorded
being 80,000.

A neuron receives information through sy-

napses located on its dendrites and soma, integrates this
information and propagates it over its axon to other nerve

pt
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cells.

We turn now to the question of how nerve impulses
spread dovm the axon.

The key to the mechanism of' this

impulse propagation are the all-or··none principle of propagation, as well as the phenomenon of passive spread.

At

any point in the axon, the action potential spreads to the
neighboring regions where the depolarization acts as a
stimulus to produce another action potential and so on
duvm the axon.

The all-or-none method of propagation

assures that the action potential will always be full'"
sized, thereby minimizing the chances that it will get
lost along the way.

In unmyelinated nerve and in muscle,

the spread of current is continuous and conduction appears
to be a uniform process.

The propagated action potential

is further accelerated by glial myelin sheaths causing
the action potential in myelinated axon to leap from node
to node.

The conduction is discontinuous or saltatory

and the impulse skips from one node to node in myelinated
nerve fibers as proposed originally by Lillie (1925). The
active generation of current(generation of action potential)
is confined to the nodes of Ranvier.

The myelin acts as an

insulator with a low electrical capacity which increases
conduction velocity by making the local circuit act at a
considerable distance ahead of the active region.

Applying

p
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the sodium permeability theory to saltatory conduction, it
can be said that sodium ions enter myelinated axons at the
nodes but depolarize the whole fiber by local circuit action.
No one has yet been able to test this particular point directly
but there is now a large body of indirect evidence in favor
of saltatory theory (Tasaki, 1939, l955).

When the nerve impulses reach the axon's synaptic terminations on a dendrite, axon or soma)nerve impulse frequency
appears to be transduced into a postsynaptic depolarization
or hyperpolarisation similar in magnitude electrically to
the one which originally generated the axon nerve impulse.
It has been shown that the arriving nerve impulse causes the
release of a small quantity of a chemical from presynaptic
terminal generically known as a transmitter substance which
diffuses across the synaptic cleft and results in the dendritic electrical response (depolarisation or hyperpolarisation).

Unlike the axonal membrane, the dendritic membrane

is said to be only chemically excitable.

Ions may depolarise

a dendritic membrane, but the release has to be induced by a
chemical transmitter.

SYNAPTIC TRANSMISSION
There is sufficient evidence to indicate that the
chemical transmitter acetylcholine (Ach) is released in uniform packets at nerve muscle junction (quanta) consisting of
a relatively large number of molecules (Hubbard, 1970).

The

pa
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quantal nature of transmission is currently thought to be consequence of the storage of Ach in synaptic vesicles found in
motor nerve terminal, ganglia and central neurons, the contents
of each vesicle forming a quantum.

Quantal release is thus equivalent to release of the
contents of a synaptic vesicle into a synaptic cleft.

Results

accumulated indicate that basically the same process is present at many peripheral and central synapses where variou.:,
chemical mediators, including Ach, are involved in the trans-mission of impulses.

The transmitter substance parcelled inside a vesicular
bag is separated from the postsynaptic target by two barriers,
the vesicular membrane itself and the membrane of axon ter
mi~al.

Release probably occurs upon the collision between

vesicular and axonal membranes.

As proposed by Katz (1966),

the release of transmitter occurs by exocytosis (collision
between vesicle and axonal membranes).

Ultrastructural evi-

dence to support this hypothesis was obtained in several
instances as in the case of secretion of zymogen granules
(Palade, 1959) and in that of neurosecretory activity
(Smith and Smith, 1966).
process is rapidly

There are suggestions that this

reve~sible

so that a vesicle having

discharged its contents would quickly detach itself from

pas
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the membrane and start reaccumulating the transmitter substance.

Similar processes occur for various transmitters

centrally and peripherally.

After the transmitter is released from its storage
site by presynaptic action potential, it impinges upon the
postsynaptic side and combines with specific macromolecules
(the receptors).

The receptors control channels in the subsynaptic membrane for the passage of Na+, K+ and Cl-.

By altering the

conformation of the receptor protein, the transmitter induce the postsynaptic potential (PSP).

The postsynaptic

potential could either depolarize or hyperpolarize the cell·
Since depolarization of the neuron results in the production
of nerve impulses, the depolarizing postsynaptic potential
is termed excitatory postsynaptic potential (EPSP).

The

hyperpolarizing postsynaptic potential is termed inhibitory
postsynaptic potential (IPSP).

IPS~

opposes the action of

EPSP's and tends to prevent the generation of action potential,

The generation of EPSP or IPSP depends upon the nature

of postsynaptic cell receptor and of the particular transmitter agent involver..

They can occur in the same cell.

P'
9

EPSP's and IPSP's arriving over different synapses
upon the neuron are summated approximating simple algebraic
addition.

The effect of IPSP is subtracted from total EPSP's.

This property is known as spatial summation.

Thus, various

inputs to a neuron combine by summation to determine the
single output.

As the dendrites are electrically unexcit-

able, there must be some region of the cell closest to the
dendrites which is electrically excitable.

This region is

believed to be axon hillock, the junction between soma and
axon.

Thus, a depolarization arising in a dendrite spreads

passively down the dendrite through the soma and finally to
the axon hillock where nerve impulses can be generated.

The

postsynaptic cell integrates and summates these potential;
when the threshold is reached it gives off in terms of the
all-or-none principle action potential at the axon hillock
which is then propagated to each of its own axon terminals
providing for the continuation of the impulse.

Summation

of the impulse is carried out by the postsynaptic cell.

NATURE AND LOCALIZATION OF THE PATHWAYS IN CENTRAL NERVOUS SYSTEM
Due to difficulties involved in studying the various
pathway in central nervous system, their nature and localization have not yet been fully determined.
have been utilized.

Various approaches

Macro- and micro-electrodes were employed

p
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to study the neuronal responses to pertinent drugs and putative
neuro transmitters • It was also attempted to demonstrate the
release of transmitter upon the stimulation of nerve tracts
and neurons.

In the case of the central nervous system,

several criteria have to be met to establish a substance as a
neuro transmitter.
(a)

The appropriate nerve soma or set of nerve axons is select-

ively stimulated and the release of the transmitter detected
upon passage of action potentials.

In the case of the brain

it is however impossible today to detect and chemically analyze
the release without destroying the functional and structural
integrity of the region of the brain being analyzed.

Further-

more, it is difficult or impossible to detect such a release
upon the stimulation of a single neuron or of a homogeneous
group of neurons.

However, the release was studied in brain

slices incubated in physiological buffer solutions in vivo.
They contain, of course, heterogeneous neuronal populations.
(b)

Indirect evidence is derived from the study of the dis-

tribution of the putative transmitters and of the enzymes
involved in the synthesis and in the breakdown of the transmitter.
(c)

Furthermore the study of the pharmacology of r'·.:sponses

to presynaptic stimulation as compared to that of the responses
to applied putative neurotransmitter may yield indirect evidence
for the role of the latter in synaptic transmission.

p
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ROLE OF Ach AS. A TRANS.MITTER IN THE CENTRAL NERVOUS

S~?..TEM

In 1954,Eccles and his associates provided pharmacological evidence for the cholinergic nature of spinal
synapses.

Acetylcholine was shown to be the transmitter

in the motor neuron collaterals to the Renshaw cell (Eccles
et al., 1954, 1956).

In the subsequent work of Eccles,

Curtis and }\yall (1958) a multimicro electrode system with
a multibarrel micropipette was employed for iontophoretic
release of drugs and for unit fire recording.
and

Ach, nicotine

cholinomimetic substance were effective in increasing

the rate of or initiating discharge from the Renshaw cell.

Searching for cholinoceptive neurons in other central
areas, Curtis and Koizumi (1961) and Bradley and Wolstencroft
(1965), Curtis and Crawford (1969) studied medullary and
mesencephalic reticular formation and the inferior colliculus.
Cells responding to Ach were found only in the latter region.
The response to Ach were not affected by dihydro f'-erythroidine,
d-tubocurarine and physostigmine.

Parenthetically, inferior

c_olliculus contains moderate amount of ChAc and ChE.

Further studies in which iontophoretic methods were
employed demonstrated that the following sites are cholinoceptive:

Caudate nucleus, ventral basal thalamus, lateral

geniculate body, the supraoptic nucleus and postomedial parts
of the thalamus, cochlear nucleus, brain stem, pyramidal cells

l2

of the cortex and certain cerebellar neurons {Curtis, 1966;
Curtis and Anderson, 1962; Curtis and Davis, 1963 and Curtis
and Eccles, 1958; Curtis and Crawford, 1969; and Krnjevic,

1974).
Furthermore, Krnjevic and Phillis (1963) suggested that
Ach may act as a sensory transmitter at the thermal receptors.
Similarly, taste fibre endings and chemoreceptors also seem to
be Ach sensitive and excitable

i~pon

application of Ach.

Two additional lines of evidence should be added.
Synaptic vesicles were found in association with Ach and miniature postsynaptic potentials in the mammalian and amphibian
brain {Katz and Miledi, 1963; Brock et al., 1951).

These

miniature potentials were not analysed phannacologically and
their presence, as well as that of vesicles, cannot as yet be
considered as

dire~t

evidence of the cholinergic nature of per-

tinent central synapses {Eccles, 1964).

Second, several investigators have shown that in the
presence of anti-ChE's, Ach is continually released from the
brain {Elliott et al., 1950; Macintosh and Oborin, 1953) and
that administration of anti-ChE agents increases l'rain levels
of Ach {Michaelis et al., 1957).
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It should be stated that pharmacological data are conclusive only with regard to cholinergicity of the synapse at
the Renshaw cell, and perhaps with certain synapses in the
cortex, thalamus and in the cerebellum, and in the supra
optic nuclei.

It is possible that central cholinergic cells

respond differentially to muscarinic and nicotinic substances.
The muscarinic response may be modulatory and facilitatory
in character, as proposed by Krnjevic (1969), this can be
also argued on the basis of analogy between the central
and ganglionic muscarinic responses (Karczmar, et al.,

1969). It should be added that Bradley and Wolstencroft (1965)
described a fast, depressant responses of certain cortical
and subcortical neurons.

Again, this response may illus-

trate the modulatory rather than synaptic role of central
Ach.

While otherwise central cholinergic synapses may be

scattered, they are presumably important in the reticular
formation and limbic system or diff'use mesendiencephalic
system.

MEMBRANE EFFECTS OF Ach:
Ach has been found to have various membrane effects
other than the neuro transmitter activity.

Ach stimulates the incorporation of inorganic phosphate
into phospholipid (Hok.in, 1966).

It has been shown that Ach
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at a concentration of l0- M stimulates the incorporation of
32p into phospholipid, especially phosphoinositol and phosphatidic acid, as demonstrated in the case of the salt gland,
sympathetic ganglia, brain slices and brain homogenates.
Current evidence suggests that Ach stimulates the .hydrolysis
of phosphoinositides in synaptosomes to form membrane bound
diglyceride; it is thought that diglyceride is rate limiting
in the synthesis of both phosphatidic acid and phosphoinositide

Ach seems to be involved in the liberation of bioactive
substances.

Itokawa and Cooper (1970) have shown that Ach

will release thiamine from perfused nerve preparations; it
has also been shown to release catecholamine from chromaffin .
cells and possibly at other sites (Glisson and Karczmar, 1971;
Burn, et aL, 1963).

Thus, Ach may also participate in the

central phenomenon by releasing active bioamines such as norepinephrine (NE) or dopamine (DE).

Ciliary movement in gill

plates of Mytilus edulis and ciliary motility in respiratory
and esophageal tracts in mammals are supposed to be controlled
by Ach (cf. Karczmar, 1963).

ROLE OF Ach IN BEHAVIOR:
A short description of the role of Ach in behavior was
included to show the importance of cholinergic system and to
justify our work on AChE.

An attempt has been made to corre-

late behavioral changes with the Ach content of the brain
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(Stein, 1970; Karczmar, 1970).
creased during convulsions.

Ach level seems to be de-

There.was an increase in Ach

content during sedation or anasthesia.

Furthermore, it was

hypothesized that the relation between the adrenergic and
cholinergic system is significant in the control of behavior.
Earlier investigators suggested that behaviorally, cholinergic
a
system is opposed to adrenergic system (Frommel et al., 1947',
b

1947 , 1951; Aprison, 1969).
this hypothesis on a more

Carlton (1963, 1964) advanced

sophjstica~ed

level.

He suggested

that cholinergic system preferentially antagonizes adrenergic
activation of unrewarded behavior and minimizes the impact of
iTrelevant stimuli.

Therefore, blockade of unrewarded behavior

by the cholinergic system should lead to better learning.

is confirmed by data of some (Whitehouse, 1959) but not all
investigators (Bignami and Rosie, 1971).

Another generalization was proposed by Rosenzweig and
his collaborators.

They associated very small differences

in AChE and Ach activity of rat cortex with "flexible" behavior.

Rats kept in complex environment showed 2-6% more

cerebral AChE activity and cortical weight than rats bred
in isolation.

Altogether, it has been suggested that cholinergic
system is responsible for suppression of avoidance and of

T4is
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non-rewarded operant behavior, for depressed overt behavior
and sleep, and for flexible response to environmental changes;
more specifically, it was shown that the cholinergic system
is involved in a number of appetitive and emotional behavior
including aggression and sexual function, temperature control,
etc.' (for references, cf. Karca.."11.ar, l975).

Finally, behavior

pattern must involve most complex circuitry, in which the
cholinergic system plays a limited if not a minor part (Eccles,
1964a, l964b; Karczmar, et al., 1971).

Thus, this system may

have simple or key role and it is impossible to assign it to
specific neurophysiological substrates of behaviors in question.

ANA.BOLIS!.1. AND CATABOLISM OF ACETYLCHOLINE:

SYNTHESIS:

Acetylcholine is synthesized in a reaction catalyzed by
choline acetyltransferase (choline acetylase):
ATP+acetate -) Adenyl acetate+pyrophosphate
Adenylacetate+Co.A. --7 Acetyl Co.A.+AMP
Acetyl Co.A. + Choline-? Ach + Co.A.
Choline acetylase
Thus, the overall reaction is
Acetate +ATP + Choline

From the

~Ach

exp~riments

+AMP + pyrophosphate

on the superior cervical ganglion

both in Feldberg's and in Macintosh's laboratories and from
the studies of Fitzgerald (1968), it appears that choline
is rate limiting in the synthesis of acetylcholine.
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Pathways involved in the anabolism and catabolism of acetylcholine are as follows:
Cytidine Diphosphate

Phosphatidyl ethanola.mine
Sadenosyl
methionine

I
1

Choline/I\
Diglyceride

Phosphatidyl
choline
-.t.-Fatty acid

CTF

Glycerophosphocholine

glyceropho~ph~

Citrate

Glucose

~
rl
Acetyl

~

/
»

~ Ach

CoA

Choline

Phosphoryl

.

Choline
~
•

> Cholin
Betaine

J,

Serine
HYDROLYSIS:
Enzymatic hydrolysis of Acetylcholine is performed
by cholinesterases which hydrolyse acetylcholine into choline
and acetic acid.
E + Ach
E Ach

-.;i.

E Ach

--=r Acetyl E

Acetyl E +

~O

+ Choline

--?> E + Acetate

It is universally agreed that cholinesterases form a family
of enzymes, isozymes and variants; in fact, we cannot be

,
18
certain how many cholinesterases exist in the body and what
are their specific roles.

This subject will be discussed now.

PROPERTIES
OF CHOLINESTERASES:
-

TYPE OF CHOLINESTERASES

Augustinsson (1963) defined cholinesterases as a group
of esterases which hydrolyse cholinesters at higher rates
than non-choline esters, when hydrolysis rates are compared
at optimum conditions as regards substrate concentration,
pH, ionic strength, etc.

Two types of cholinesterases most

frequently encountered in mammals are the serum enzyme designated at various times as pseudo or non-specific S-type
ChE and at present as cholinesterase (EC, 3.1.1.8) and the
true, specific or C-type ChE, at present designated as
acetylcholinesterase (AChE) (EC, 3.1.1.7).

Other related esterases are

kno~m.

Ali- and aryl-

esterases do not hydrolyse choline esters while they are
effective against alkyl and aryl esters respectively.

These

and other ChE's may be distinguished by their inhibitory characteristics; as shown early by Mounter and Whittaker (1950).
ChE's are inhibited by organophosphorus compounds

and

carbamates, aliesterases are inhibited by organophosphorus
compounds but not by carbamates, while aryl ester?ses are
inhibited by neither organophosphorus compounds nor carbamates.

The organophosphorus anticholinesterases such as

jP
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diisopropyl phosphofluoridate (DFP) are generally more potent
inhibitors of cholinesterases than of acetylcholinesterase,
whereas oxamide derivatives (Ambenonium) are about two thousand
times more potent as an inhibitor of acetylcholinesterase than
of cholinesterase (Lands et al., 1955).

In the further discussions, AchE will refer to true or
specific cholinesterase, BuChE will refer to pseudo or cholinesterase.

The two groups AchE and ChE may be differentiated generally
not only by means of selective inhibitors, but also by means of
specific substrates.
other choline esters

AchE hydrolyses Ach most ra:e_i.<!lz, but the
~ slow~z.

AchE is inhibited by high

substrate concentration; when the hydrolysis rate obtained
with pure AchE is plotted against the logarithm of substrate
concentration, bell shaped curves are obtained.

The optimum

substrate concentration for the AchE - Ach system is at about

3xio-3M and the dissociation constant (Ks} for the AchE-Ach
complex is about 5x10-~.

All ChE's so far studied split

butyryl choline at a higher rate than other esters of choline

3

and give the usual dissociation curves (Ks-2xl0- ) with butyryl
choline, propionychr.line and Ach.

The esterase activity is not

inhibited by high concentrations of these substrates.

20
ACETYLCHOLINESTERA.SE:
Acetylcholinesterase is of particular importance because
of its role in synaptic and neuroeffector transmission.

AchE

has been analyzed thoroughly at the molecular level by various
workers, beginning with Nachmansohn and Wilson (1951).

Acetyl-

cholinesterase has been crystallized from electric eel (Kremzner
and Wilson, 1964).

An electrophoretically homogeneous moiety

·was found to have a molecular weight of 240,000 (Leuzinger and
Baker, 1967).

Nachmansohn and Wilson (1951) found the two main subsites
at the active centre of AchE, one being the anionic site which
attracts the positive charge in Ach; second, about 5'A distant
from the anionic site, the esteratic site which bindsl the
carboxyl carbon atom of Ach.

It has been shown that the

anionic site contains at least one carboxyl group present
probably in the glutamate component (Cohen et al., 1959).
The esteratic site involves a histidine residue adjacent to
serine (Bergmann et al., 1956).

Most of the information on the active centre has been
obtained using appropriate anticholinesterases.

In the

study of the esteratic site, radioisotopes (32p or 14c) of
organophosphorus reagents were reacted with the purified
enzyme, the labelled protein was hydrolysed and the radioactive products were isolated and identified (Michel and
Krop, 1951).

The sequence glycine-glutamine-serine-alanine-
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glycine-glycine (Jansz et al., 1959) established for the esteratic site of ChE is typical and Cohen et al., (1955) hypothesize~

that a number of DFP-sensitive enzymes carry a similar

structure which react with DFP, the radioactive organophosphorus residue being coupled with serine.

Several models were suggested to explain hydrolytic activity of AchE's as well as their inhibition.

Bergmann et al,

(1958) suggested that the acidic group in the esteratic site
forms a hydrogen bridge with ethereal oxygen of Ach and is
active in the hydrolysis of enzyme-substrate complex.

Other

model systems of Ach hydrolysis stresses the significance of
serine hydroxyl activated perhaps by imidazole and of the
carboxyl grouping (Cunningham, 1957; Fahrney and Gold, 1963).
The serine hydroxyl and the carboxyl group may form an internal
ester or carboxylate ion.

This carboxylate nucleophilic center

is capable of intra molecular attack on the carboxyl atom of
the ester to produce rapidly hydrolysed anhydride.

Anionic sites may be necessary with regard to interaction between the substrate molecule and ChE.

Results obtained

with bisquaternary inhibitors suggest (Bergmann, 1955) that
anionic sites occur in pairs in the vicinity of the esteratic
site and that they consist of the Y carboxylic groups of an
y-gluta.myl peptide.

It is by no means certain that quaternary

22
nitrogen of these inhibitors react with the same site as the
cationic head of Ach; thus, the enzyme may contain several
anionic sites.

ISOZYMES OF ACETYLCHOLINESTERASE AND CHOJJINESTERASE:
According to Markert and Moeller (1959), isoenzymes are
enzyines which have the same catalytic action and are derived
from the same organ, but have different chemical and/or
physical properties.

Many authors have pointed out (eg.

Wieland and Pfeiderer, 1962; Kaplan, 1963) that the multiple
molecular forms of an enzyme are only of significance when
they do not arise as artifacts of purification.

Dubbs (1966)

disagrees with their viewpoint; he believes that a ChE isoenzyme
which is observable after ultrasonic treatment of serum and not
observable without such treatment is not a mere artifact but
a significant entity.

However, it is probably that an iso-

enzyme arising after ultrasonic treatment may be an artifact.

Human serum cholinesterase has been separated electrophoretically (Dubbs et al., 196o; Bernsolm. et al., 1961, 1966) into
at least seven distinct bands, each of which may be referred
to as an isoenzyme (Webb, 1964).
electrophoresis of
zymes.

huma~

Juul (1968) employed disc

serum ChE; he identified twelve iso-

Almost 803 of the total ChE activity was pr.esent in one

isozyme (chE ).

7

In adrlition to electrophoretic separation of

ChE isozymes, it has been possible to fractionate human serum

,
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ChE into component isozymes by gel filtration on sephadex

G-200 columns (Harris and Robson, 1963) and also by chromatography on DEAE cellulose columns (Liddell et al., 1963).

In a study of properties of ChE isozymes, Ecobichon and

Kalow (1963) removed the sialic acid residues of human serum
ChE and found that although electrophoretic mobility was
affected, the kinetic properties of the product remain unchanged.

La Motta et al., (1965) demonstrated that five of

the isozymes of human serum ChE are interconvertible and represent different stages of polymerization.

La Motta et al.,

(1966) later were able to show that all seven serum ChE isomers
are interconvertible polymers, each containing the same polypeptide unit.

Barron et al., (1962) have separated the AchE of human
brain into isozymes.

Ecobichon and Israel (1967) found not

only four isozymes of AchE but also two weak bands of ChE and
one band of nonspecific carboxylesterase in the electric organ
of electrophorus electricus.

Massoulie and Rieger (1969)

found three main molecular species (A, C and D) exhibited
acetyl cholinesterase activity in the extract of torpedo
electric organ.

Thi.s was observed in fresh frozen organ

extracts, toluene-autolyzed organ extracts, or autolysis
exudates.

The fourth species, B, appeared during autolysis
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in the exudate.

These species were found to be stable even

after treatment with various drugs.

Molecular species C and

D show the phenomenon of aggregation in low salt concentration whereas A and B do not.

Rieger et al.,

(1973) differentiated the several forms of

AchE by their sedimentation constant and by their structure.
They separated them into globular and elongated forms.

Elonga-

ted forms were in turn separated into forms of various

sedime~

tation coefficient A

(8,55),

C

(14.25),

and D

(18.45).

By

using different antibodies they found that the elongated forms
were more reactive than the globular forms with each antiserum
tested.

Neuraminidase treatment decreased the affinity of

antiserum for the D and C forms but not for the globular
forms following treatment with neuraminidase.

This would imply

that polysaccharides are important for the structure of elongated forms.

INTERACTION OF CHOLINESTERASE AND ACETYLCHOLINESTERASE WITH
IRREVERSIBLE INHIBITORS:
Enzyme inhibitors may be classified as reversible or
irreversible.

As used by enzymologist, the term reversible

means that the inhibitory action may be reversed easily, e.g.
by removing the

inhibitor by dialysis.

In the case of irre-

versible inhibitor, the inhibitory action is not easily reversed
and the amount of inhibition will increase progressively until

p
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the enzymatic activity is nullified,

provided large a.mount

of inhibitor is present.

The most potent and well characterized irreversible inhibitors of ChE fall into three classes:

Organophosphorus

inhibitors, carbamates and organosulfonates.

MECHANISM OF IRREVERSIBLE INHIBITION
The degree of inhibition observed with an irreversible
inhibitor depends on the rate constant of inhibition {Kl)

---- E + I

~

EI

The inhibitor cannot be recovered intact from an enzyme inhibited by an irreversible inhibitor.

Irreversible inhibi-

tion has been shown to occur as a multistage process:

a re-

versible formation of an enzyme-inhibitor complex is followed
by an irreversible phosphorylation of the enzyme {"aging", cf.
below).

It is not true that enzymatic activity can never be

recovered from enzymes inhibited with irreversible inhibitors.
However, even though the enzyme may be recoverable {cf. below)
the inhibitor is not recoverable.

Thus, in the case of inhibi-

tion of ChE by the organophosphorus compound sarine followed
by reactivation by pyridine-2-aldoxine methiodide (P-2AM),
ChE activity is restored but the sarin moiety is removed
from the E+I compound as phosphoric acid rather than as the
phosphonofluoride.

The acid is not a ChE inhibitor.
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REACTIVATION:
Reactivation of irreversibly inhibited ChE is the process
by which enzymatic activity is restored to the inhibited enzyme.

This process may occur as the result of interaction

with the solvent in which case it is referred to as spontaneous.
Reactivation may also occur as the result of the action of some
compound added to the reaction mixture for the purpose.

For

reactivation to be possible, the native structure of the enzyme
should be retained through the inhibition and reactivation
steps (Berendes, 1964).

The phenomenon of aging in which

the ability to reactivate the inhibited enzyme is lost as the
result of a chemical or physical reaction, is discussed later.

REACTIVATORS:
Almost all of the presently known effective reactivators
contain a quaternary nitrogen group separated from a reactive
group by a distance which is approximately the same as the distance between the anionic and esteratic sites of ChE.

The

discovery of reactivators may be traced to the finding of
Hestrin (1949) that intact AchE and hydroxamate are released
upon incubation of acetylated enzyme with hydroxylamine.

It

was shown that, just as it can be acetylated, hydroxylamine
can be phosphorylated by organophosphorus agents (Green and
Saville, 1956) and that phosphorylation of reactivators
follows their contact with phosphorylated enzyme which is
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then reactivated (Wilson 1951, 1952).

Among important factors in reactivation are the extent
of the formation of protonated acidic sites, as indicated by
relevant pH studies (Wilson et al., 1958) and the degree of
nucleophilicity of the reactivator which depends upon the
substituents on the hydroxamate or oxime anion.

In 1959,

Wilson suggested that a good reactivator could be .obtained
by combining a nucleophilic group with suitably placed quate!:nary nitrogen atom.

These and previous findings led Wilson

to development of monoquaternary pyridine aldoximes such as
pyridine 2 aldoxime methiodide and pyridine
dide (P-2AM and P-4AM).

4 aldoxime methio-

Wilson (1958, 1959) suggested that

an ideal reactivator should be bound to the organophosphorus
inhibited enzyme so that a nucleophilic grouping such as the
oxygen should fall one cond length from the phosphorus atom.

Reactivators are important not only for theoretical
studies as they can be used in vitro but are also very practical in their applicability for the treatment of poisoning
by anti ChE agents and for prophylaxis against such poisoning

{Wills, 1963).

AGING:

Aging is a process in which inhibited enzymes become
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refractory to reactivation.

In the case of acetyl and cholin-

esterase an irreversibly inhibited. (e.g. phosphorylated) enzyme which can be at first reactivated by high concentrations
of reactivator is transformed subsequently to a form that
cannot be reactivated (Heilbronn-Wikstrom, 1965).

At present,

it is generally thought that aging depends on the change in
the phosphoryl moiety (Jansz et al., 1959).

Berendes (1968)

postulated that the reaction involved in aging is due to hydrolysis of one alkoxy group f:·om pho.sphorylated enzyme:

(OR)

ro - E + HO ---7' (OR) (OH) ro E + ROH

.l..

The evidence for this is as follows:
In a normal reactivation process of DFP inhibited enzyme,

32
P was released as diisopropyl phosphate, whereas in an aged
sample it was released as monoisopropyl phosphate by alkaline
hydrolysis.

The refractory portion of the phosphorylated

enzyme was a hydrogen phosphate known to be resistant to
nucleophiles (Heath 1961).

Inhibition followed by aging.is an important and an
useful mechanism which can be used to study the synthesis of
AChE.

The enzyme which arises following inhibition with DFP

represents the newly synthesized enzyme.

The irreversible

inhibition can, therefore, be used to study the tlll'nover rate
of AChE.

From the amount of inhibited enzyme,

ti~e

50% of the enzyme to be synthesised is determined.
value, turnover rate of the enzyme was calculated.

taken for
From the
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INHIBITION OF ACETYLCHOLINESTERASE BY DFP
WITH REVERSAL OF THE INHIBITION BY 2 PYRIDINE
ALDOXIME METHIODIDE

I AchEI

I

Esteratic site

+

Serine

I

OH

J

DFP

This diagram illustrates the irreversible inhibition of
AchE by diisopropyl fluorophosphate as due to phosphorylation of AchE through the serine hydroxyl present at
the esteratic site.

Cohen et al., (1955)

i

_J
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0-CH=NOH

+

e I Ea N

I

CH3

Pyridine
2 Aldoxime Methiodide

I AchEI

'.

+

Serme

I
OH

This diagram illustrates the reactivation of DFP inhibited
AchE by pyridine 2 aldoxime methiodide. As a result of
this process, the reactivator becomes phosphorylated.

WILSON (1959)
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DISTRIBUTION OF ACbE IN THE CENTPAL NERVOUS SYSTEM:

l) Subcellular Distribution:
The cytological distribution of AChE in the central
nervous system appears to resemble the pattern observed in their
peripheral counterparts, in that the concentration is greatest
at the membrane, ·while lesser concentrations of AChE are also
present in the cytoplasm as well

as

along the length of the

processes insofar as they can be traced.

This could be demon-

strated histochemically (Fukada and Koelle, 1959).

In frog

nerve and brain, the highest activity of ACbE was found in the
particulate fractions especially in the microsomes,in the
membranous materials, less amounts of ACbE were found in the
mitochondria (Clouet and Waelsch, 1961a,b).

The type of cholinesterase found in tissue is often a
reflection of the tissue.

Neural tissue contains ACbE while

non-neural tissue contains ChE.

In the blood of most mannnals,

erythrocytes contain only ACbE while plasma contains ChE
(Zajicek and Datta, 1953).

2) Tissue Distribution:
Histochemical studies indicate that medulla, reticular
formation, midbrain and caudate nucleus were those brain areas
which exhibited highest. concentrations of ACbE (Holmes and
Wolstencroft, 1964; Koelle, 1954 and 1963; Shute and Lewis,
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l963).

Primary efferent neurons were low in AChE.

However,

activity of AChE increased progressively in the tertiary and
secondary sensory relay neurons.

The cerebellar cortex of

several ma..111Ilialian species and of the duck also contained
AChE (Phillis, l965).

Many AChE-containing fibers were found

in cerebellar peduncle (cf. Karczmar, l969).

In tissue culture,

cortical AChE appeared to be presynaptic while glial cells from
cortex and elsewhere in the brain contained ChE (Geiger and
Stone, l962).

In the cat retina, high AChE activity was confined to

the innermost region of the inner nuclear layer and to a band
extending from the inner zone of the inner plexiform to the
outer part of the ganglion cells (Koelle et al., l952).

The

high staining in the cytoplasm of amacrine and ganglion cells
seems to indicate that these cells are cholinergic.

The four

stained synaptic bands represent regions where the axons of
amacrine and bipolar cells synapse with the dendrites of
ganglion cells which might contain ACh as transmitter.

Cells

which are capable of responding to ACh and contain AChE, CbAC
are considered cholinergic.

In the auditory system highest concentration of AChE
were noted in the neighborhood of the nerve chalices terminating on the inner rows of hair cells and in the efferent
nerve fibers of the olivochochlear bundle, oriented towards

-

----

--·--·----
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the organ of Corti (Rossi and Cortesina, 1961).

As this study deals with the properties of the nerve
endings in the synaptosomal preparations, certain properties
of the synaptosomes will be discussed below.

PROPERTIES OF SYNAPTOSOMES:
Preparation:

During homogenization of the brain tissue

in isosmotic aqueous sucrose, the central presynaptic nerve
terminals seal off and form detached particles away from
axons (Gray and Whittaker, l96o, 1962).

Whittaker et al.,

(1964) called these detached particles "synaptosomes".

These

synaptosomes retain the morphological nature and chemical
content of the intact presynaptic terminal (including the
transmitter).

By

differential centrifugation they can be

separated from other organelles (mitochondria, myelin) and
provide a new type in vitro preparation particularly appropriate for neurochemical studies of neuronal function.

Various types of central nerve terminals from various
parts of the brain have been observed to :form synaptosomes
during homogenization; for instance, the mossy fiber endings
of the cerebellar cortex are a good source of syriaptosomes.
The following discrete regions were shown to form synaptosomes;
cerebral neocortex, hippoca.mpus, caudate nucleus (Laverty et al.,
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1963), spinal cord, hypothalamus (Michaelson et al. , 1963),
and hypophysis (Labella and Sanwal (1965).

Brain parts of

various species such as the mouse (Weinstein et al., 1963),
rat, guinea pig, rabbit, cat, dog and man (Siakotos) form
synaptosomes during homogenization.

However, the richly

innervated peripheral tissues show a very low yield of
synaptosomes.

On subjecting the synaptosomes to osmotic

shock, they may be further fractionated into soluble cytoplasm,
::·ynaptic vesicles, external synaptosomal membrane and intrater!"uinal mitochondria

Morphological aI1d chemical ana.lysis

of these fractions give a good picture of organization of the
pre-synaptic terminal.

Normally synaptosomes should be free

of microsomes except those which arise during preparation.

METHODS OF PREPAR!'\.TION:

The methodology of the synaptosomal preparation is de- ·
scribed below (cf. Methods); a general outline will be presented at this time.
structures.

Synaptosomes are osmotically sensitive

In isosmotic media, any kind of chopping, minc-

ing or dispersion of the tissue probably permits the survival
of a considerable proportion of them as organized structures.
Synaptosomes have sedimentation properties which are broadly
similar to those c·.:' mitochondria and of the smaller fragments
of myelinated axons, dendrites and glial processes formed during
homogenization.

,
35
The mitochondrial fraction obtained from sucrose homogenates of brain tissue by differential centrifugation is a
mixture of all these components.

Synaptosomes can be separated

from myelin and mitochondria by making use of differences in
equilibrium density in a sucrose density gradient.

Myelin

floats on 0.8M sucrose, whereas synaptosomes have an
mediate density (between mitochondria and myelin).

in~~

In our

study we used gradients of Ficoll made isosmotic with sucrose
(Kurokawa et al., 1965).

Electron microscopy analysis indi-

cates that these preparations are as intact as those obtained
using sucrose as a density gradient; in some instances better
respiratory activity of mitochondria was retained.

Thus, a

fraction rich in synaptosomes and essentially free from myelin
and somatic mitochondria may be obtained by centrifuging a
crude mitochondrial fraction in a five step discontinuous ficoll
gradient consisting of 20%, 13%, 10%,

7.5% and 5% layers that

have been allowed to diffuse into each other l~ hours before
use.

Flow chart for this isolation is shown in the Method

Section.

Once formed the synaptosomes are relatively labile structures; they are readily disrupted by variety of treatments,
e.g. warming, vigorous mechanical agitation, supersonic vibrations, detergents, freezing or thawing and hypo-osmotic treat-

,
ment.

Most of these treatments result in the prompt libera-

tion of soluble cytoplasmic components

Hypo-osmotic disruption

provides the most suitable procedure so far found for the isolation of the constituent organelles of the synaptosome.

Large

number of synaptic vesicles survive intact, external membrane
and intraterminal mitochondria are not unduly fragmented and
can be separated from vesicles by centrifuging

3)

Morphological

characteri~tics o~

synaptosomes:

Synaptosome fractions can be prepared for electron
microscopy by any of the standard methods of fixing, staining and embedding nervous tissue that gives a good preservation of nerve terminals in whole tissue

blo~k.

Electron

microscopy method which we employed are discussed in detail
in Method Section.

In section, synaptosomes appear as membrane-bound, oval
shaped bodies containing numerous vesicles and sometimes small
mitochondria.

Generally, sections of thickened membrane can

be seen which are attached to the extra synaptic membrane; a

•
cleft at about 200A can be seen between the membranes.

In

addition, most synaptosomes contain a few larger vesicles and
dense core vesicles.

It is assumed that on homocenization

the terminal region of the axon is pinched off and seals up
to form a subcellular particle which carries with it a length
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of the characteristically thickened post-synaptic membrane
of next cell.

In viewing the EM picture, it must be kept in

mind that even if all synaptosomes possess post-synaptic attachments and mitochondria as well as synaptic vesicles, only certain planes of section will contain all three structural components (Whittaker, 1963).

IN VITRO USE OF SYNAPTOSOMES:

The synaptosome as a pinched off cell process has within
its external membrane, alcytoplasm containing a normal complement of glycolytic enzymes and one or more mitochondria.
thus may be regarded as a small, non-nucleated cell.

It

Synapto-

somes have been used in vitro to study the synthesis, storage
and release of transmitter (Krnjevic and Whittaker, 1965) and
for sampling terminal axoplasm in studies of axonal flow
(Barondes, 1966).

Various workers (Austin and Morgan, 1967a)

have used the synaptosomes for the investigation of the problem
of the site of synthesis of axonal proteins, particularly those
contained within membranous structures.

Synaptosomes do in fact actively respire when warmed and
provided with

substrate~

They also synthesize high energy

substrate, take up choline by a Na

+

dependent Hemicholinium

sensitive mechanism and possess a membrane with passive permeability properties similar to those of other non-royelinated
neurons.

Active transport have not been shown in synaptosoroes

,
so also depolarisation.

DNA has never been found in synapto-

Austin and Morgan (1967) found RNA in unfractionated

somes.

and fractionated synaptosomes.

ENZYMES:

Synaptosomes in general host a number of enzyme systems,
including enzyrnes responsible for synthesis and degradation of
various transmitters, as well as enzymes concerned with protein synthesis.

Synaptosome cytoplasm is believed to contain

a full complement of glycolytic enzymes.

Enzymes of external

synaptic membrane include cholinesterases and Na+K+-activated
ATPase.

Synaptic vesicles contain only one enzyme Mg++-activa-

ted ATPase in low activity (Hosie, 1965).

TRANSMITTER CONTENT:

Acetylcholine, noradrenaline,· dopamine, hydroxytryptamine,Y'-amino butyrate and glycine are found in appreciable
concentrations in any synaptosomal fraction.

If the synapto-

somes were prepared from specific areas in the brain, they can
be shown to be rich in one or two specific transmitters.

It

is now known that most cholinergic neurons in marrnnalian brain
form part of great ascending system, the reticular activation
system which terminates on cortical and striate neurons (Lewis
and Shute, 1966).

Th:Us

7oo/o

of the total acetylcholine of the

,
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forebrain remains in a bound form on homogenization and much of
it is recovered in the synaptosomal fraction.

Glycine in the

spinal cord and gamma amino butyrate in the cortex are strong
contenders for the role of inhibitors.

In the forebrain, they

both show the type of distribution predicted for the transmitter
of an inhibitory neuron (by electrophysiological studies).
Further the amount of gamma amino butyrate in cortical synaptosome preparations is

ade~uate

to sustain a transmitter role

(Whittaker, 1968).

PROTEIN" SYNTHESIS IN ISOLATED SYNAPTOSOMES:

In vitro studies:

The synaptosomal fraction of a mammalian brain is a usefUl

in vitro system to study neuronal and synaptic f'unction,

since morphological and biochemical evidences have shown their
intactness and relative purity (De Robertis, et al., 1963;
Whi:taker et al., 1964).

They are intact and pure without

contarnination from other organelles.

They are intact and pure,

the way a mixture of cells are.

Synaptosomal preparations have been used in vitro to study
protein synthesis.

In studying protein synthesis in such sy-

stem, the misinterpretation of the results due to contamination
from subcellular particles are microsomal, mitochondrial and
bacterial components capable of protein synthesis should be
eliminated.

For this reason, specific protein synthesis inhibi-

tors are used.

,
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Inhibitor or enzyme

Mode of action

Reference

DNAse

Hydrolyses DNA 3'5'-phosphate
does not affect mitochondrial DNA

Winters berger
(1966)

RNAse

Hydrolyses ribosomal RNA but
does not affect mitochondrial RNA

Roodyn et al.
(1961)

Cycloheximide

Specific for eukaryotic ribosomal systems, but not mitochondria

Ennis and Lubin
(1964)
Siegel and Sisler
(1965)

Chloramphenicol)
Tetracycline
)Af~ects bacterial and mitoErythromycin
) chondrial systems
Lincomycin
)
Actinomycin-D

Puromycin

Inhibits DNA-dependent RNA
polymerase including mitochondrial polymerase

Clark-Walker and
Linnane (1967)
Winters berger
(1966)

Inhibits brain ribosomal
Campbell et al.
system
(1966)
Inhibits mitochondrial system Kroon (1964)

Specific inhibitors added to the incubation medium which contains the labelled amino acid, inhibits protein synthesis
arising due to specific organelles.

For instance, cyclohexi-

mide inhibits the protein synthesis arising from the ribosom.al system whereas chloramphenicol will inhibit the protein
synthesis of the bacterial and mitochondrial system.

The work of Autilio et al (1968) showed that brain synaptosomal preparations are capable of incorporating amino acid
into proteins in vitro.

They ruled out the contamination by
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bacteria, microsomes and mitochondria that may have been
present outside the nerve endings by using specific inhibitors.
Bacterial contribution to protein synthesis was excluded from
the limited inhibition they found with chloramphenicol
and also the short

(25%)

period of linear protein synthesis in synap-

tosomes compared with exponential rate of synthesis in bacteria.
By

using ribonuclease or by adding supernatant enzymes or mi-

crosomes, no alteration was found in the rate of synaptosomal
protein synthesis.

This excluded the contribution of extra

synaptosomal ribosomes or microsomes to the protein synthesis .

.

Austin and Morgan (1967) demonstrate that labelled microsomes
added during homogenization of brain tissue are not incorporated into the synaptosomal fraction.

In addition, protein

synthesized in synaptosomes sedimented differently in sucrose
gradients from those synthesized in microsomes.

As regards to

elements within synaptosomes responsible for protein synthesis,
they suggested that within the nerve ending particles,

75%

of

the radioactive protein may be synthesized outside mitochondria
and

25%

within mitochondria.

These conclusions were reached

following use of various inhibitors.

Austin and Morgan (1967) studying a cell free synaptosomal
preparation found that the rate of incorporation of 14c leucine
was linear and decreased with age.

F
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Rate of incorporation of leucine with animal age in months

On the basis of the results obtained with protein synthesis inhibitors, Morgan and Austin (1968) suggested that synaptosomes can be considered as an anucleated mammalian cell which
exhibits two protein synthesizing systems.

The mitochondrial

system is sensitive to chloramphenicol and chloramphenicollike antibiotics tetracycline, erythromycin and lincomycin
whereas the membrane system is sensitive to cycloheximide.
Morgan and Austin (1968) found release of labelled fragments
(following incorporation of

14C leucine)

upon subjecting pre-

parations containing synaptosomes to osmotic shock.

The only

osmotically-sensitive structures in their preparation were the
synaptosomes

The release of material upon osmotic shock is

therefore a good indication that the material originates from
the synaptosomes.

Bachelard (1966) suggested that protein synthesis in
synaptosomes might be entirely due to the presence of synaptosomal mitochondria which presumably transport
soluble fraction to the membrane.

protein via the

Normally chloramphenicol

should inhibit mitochondrial protein synthesis and should

f
prevent release of mitochondrial proteins to other fractions.
As this did not occur with chloramphenicol in their work, a
contaminated synaptosomal preparation may have been involved.

Goldberg

(1971) studied protein synthesis in mitochon-

dria and nerve endings and compared the incorporation of
14 c-leucine under identical incubation conditions.

He found

that both fractions had similar requirements for sodium and
potassium activation, with concentrations of lOOmM and lOmM
respectively producing maximum levels of incorporation.

He

suggested that the mechanism of protein synthesis in nerve
endings and brain mitochondria was similar and similar
synthetic systems are present in the mitochondria and nerve
ending fractions.

EVIDENCE FOR AXONAL RNA:
Despite the fact that the electron microscope has failed
to reveal the presence of ribosomes within the axonal and
synaptic regions of neurons, (Palay and Palade,

1955) there

is evidence indicating that protein synthesis proceeds in isolated synaptosomes.

There must therefore be a specialized

site and mechanism concerned with protein synthesis at the nerve
endings.

Evidence for the presence of RNA in the axon is readily
available today.

By using ultra microanalytical procedures,
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Edstrom (1964) demonstrated RNA in the Mauthner axon of gold
fish and in the lobster stretch receptor neuron at a concentration of 0.05% (wt/volume).

This concentration paralleled

that found for the myelin sheath; high concentration of RNA
were present both in the proximal and distal regions of the
axon (cf. Tuble below).

Content of RNA in 200 pl pieces of Mauthner axons and
myelin sheaths from the gold fish (Edstrom et al., 1962)
Method of extraction:
Experiment 1
Formalin Fixation
Myelin
Axons
Sheaths

Experiment 2
Carnoy fixation
Axons

0.4mg RNase/ml
dist. water ~H-6.o
3 hours, 37 C

93.:t,10

Control dist. water
pH6.o, 3hrs. 37°C*

15.9

25.6

30.9

Difference

38

68
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Mean values in )f}l-g.:t, S E. of the mean
*Either without.any added enzyme or with

0.4mg of ultraviolet

inactivated RNase.
The base composition of RNA in the axon and myelin sheath
although variable differed distinctly from that of ribosomal
RNA.

On the other hand, the base composition of RNA in the

cell body is similar to that of ribosomal RNA l.e. it is rich
in guanine and cytosine.

Edstrom et al., (1962) pointed out

p

that this is compatible with the absence of ribosomes from
the axons as determined by electron microscopy (Palay and
Palade, 1955).

The long period of time that a messenger RNA would need
to traverse the length of long axons and reach the terminals
would require a highly stable messenger to survive the trip.
Thus Edstrom (1962) believes that protein synthesis ~n distant
portions of the axon is not directed by messenger RNA which
was made in the perikaryon and that there is evidence for
local synthesis of RNA in axons.

Koenig (1965) reported that denuded myelin free axons
from the spinal accessory nerve of the rabbit contain RNA in
concentrations far smaller than that found in Mauthner axon,
that is, about 1/1000 as great as that of perikaryon.

Koenig

(1967) found also in vivo incorporation of 3H leucine into
axonal protein and of

~-erotic

he believes to be axonal RNA.
degraded by RNase.

3
acid and H-adenine into what
Some of the latter material is

Actinomycin did not inhibit leucine incor-

poration into protein while it inhibited precursor incorporation into RNA; this suggests local RNA synthesis (Koenig,

1967). These results indicate that RNA and

prot~in synthesis

in axons might be a general phenomenon (Edstrom, ~962).
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This concept is supported by the data of Austin and
Morgan (1967).

They analyzed RNA in purified subfractions

from rat cortex synaptosomes and found in unfractionated synaptosomes 12 pg of RNA/mg protein; in synaptosome ghosts
20 vg/mg protein; in the membrane subfraction E 14 µg/mg pro-

tein (subfraction E contains membrane fragments of microsomal
dimension and some synaptic vesicles); in the subfraction F
21 µg/mg protein (fraction F is believed to consist mainly of
extra synaptic membrane and synaptosomal ghosts).
mal fraction contained

The microso-

40 µg/mg protein.

Koenig (1968) hypothesized that axonal membrane is omnipotential .or omnivalent in terms of its functional properties
as the information specif'Ying the characteristics of its protein
is found throughout the membrane.

It was postulated that tran-

slation of encoded information is controlled by local extra membrane DNA dependent mechanisms which could either be extra or
intracellular.

According to Koenig, it should be possible to

bring about a transduction of a given membrane region under
proper conditions from one f\lnctional type to another.

It

appears altogether that there is strong evidence regarding the
protein synthesizing capacity of synaptosomes and that it is
likely that synaptic membranes synthesize their own protein
and including the enzymes such as AChE.

THE AIM OF THE RESEARCH PROBLEM

One important element in the organization and f\lnctioning of the central nervous system is determined by the pattern
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of synaptic connection between cells and the efficiency of
such synapses in interneuronal communication.

liiany of the

electrical characteristics of synapses have been elegantly
evaluated by electrophysiological techniques (Eccles, 1964).
Yet, our understanding is still extremely limited as regards
the biochemical events which may be rate-limiting in the intracellular transfer of information.

Proteins are obviously im-

portant with respect to the metabolism of neuro-transmitters,
the structure of membranes of the nerve terminals and the
synapses as well as with respect to other vital components of
conduction as well as of the chemical transmission from one
cell to another.

An understanding of macromolecular metabolism,

therefore, becomes critical for an understanding of synaptic
:f'unction.

To understand the metabolism of an important macro-

molecule like AChE at the synaptic junction is crucially important due to the specific role of this enzyme in transmission
and as this knowledge may explain the general phenomenon involved in the structurization of the synapse.

The synapse may be considerably removed from the cell
body and its nucleus.

To meet its macromolecular require-

ments, the appropriate proteins must either be synthesized
at the synapse or migrate from cell body to the synaptic
junction.
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It was shown in the classic study of Weiss and Hiscoe

(1948) that after an application of a ligature around a nerve,
the diameter of the nerve on the cell body side of the ligature increased, whereas it decreased on the peripheral side
of the nerve.

Following the removal of the ligature the

diameter of peripheral segment returned to normal at the rate

1nun per day.

The conclusion from those experiments was ines-

capably that there was a constant movement in a proximo distal
direction and that any local th.L·ottling of the progress of that.
movement resulted in the piling up of neuronal content.

Weiss and Hiscoe

(1948) proposed the phenomenon of axo-

plasmic flow or axoplasmic transport as the mechanism by means
of which the nerve tissue located at·a distance from the cell
bo~

receives various substances such as proteins and enzymes

from the cell body following the synthesis at that site.

The biochemical study of axonal flow by means of isotopes
has become widespread and a wide body of information has been
obtained with the use of labelled compounds.
injection of labelled amino acid Miani

Following the

(1964) and Ochs (1966)

examined a series of segments of a nerve at various intervals
of time; progressive mi.gration of the labelled amino acid was
demonstrated in these experiments.

f
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Using labelled amino acid, a rate of lmm per day has
been observed for migration of labelled proteins down the axon
(Droz, 1965; La.sek, 1966; Weiss, 1967).

These experiments

involved the peripheral nervous system.

Barondes (1964) has

postulated a similar axonal flow within the central nervous
system.

On the other hand, there are data suggesting that

proteins may also be synthesized at synaptosomal sites
(cf. above), and it is possible to infer that protein synthecis occurs in synapses from the observation that brain slices
incorporate radioactive amino acids into synaptosomal protein
"rithout any appreciable time lag (Austin and Morgan, 1967).

We undertook to study specifically the genesis of AChE
in synapses in the central nervous system.

As AChE is local-

ized at the external membrane of synaptic endings in cholinergic neurons, a mechanism must exist by means of which AChE
could be either transported to or formed at this region without hydrolyzing cytoplasmic ACh present presynaptically.
Preliminary evidence was obtained in the peripheral system
suggesting that the enzyme may be formed in the cell body and,
then move down an axon; it may be possibly attached to neurotubules acting as a carrier, (Ochs, 1963).

On the other hand,

evidence for local synthesis of the enzyme in axons has also
been adduced (cf. above).

These experiments were carried out

with respect to peripheral nerve employing sectioning tech-

f
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niques as well as anticholinesterases.

Koenig (1965a,b) has

been actively pursuing the study of axonal AChE synthesis.
Cat bypoglossal and cervical sympathetic nerves and the bypoglossal nucleus were assayed for AChE on day 1,3,5 and 10
after the administration of a high dose

(4op. moles/kg I.V )

of DFP; the resynthesis of AChE following its inhibition by
DFP with and vlithout axotomy was studied.

Resynthesis of

AChE was constant all along the various segments of peripheral
nerve studied at each time interval.

Koenig noted a loss of

AChE from the perikaryon with a corresponding suppression
of the somal synthesis

dur~ng

outgrowth of regenerating axon

while the enzyme continued to be synthesized locally in the
axon.

The restoration rate of AChE activity in hypoglossal

nerve following DFP was of order

7% per

~y.

On the basis of

these data, they proposed that axonal proteins which are synthesized in perikaryon remain as constituents of axoplasm
whereas axolemma.-bound structural proteins and enzymes such as
AChE are synthesized by a local axonal mechanism.

We undertook to study the genesis of AChE in synapses
in the central nervous system.

The problem to be investigated

was whether AChE arrives at the terminal by axoplasmic transport following its synthesis in the microsomes

in the cell

body or whether it is synthesized at the nerve endings.

This

study was therefore carried out to understand the mechanism of

p
51
AChE synthesis in the nerve ending fraction.

We pursued

this study in rat brain by following the resynthesis of
AChE after irreversible inhibition of the enzyme by DFP.
Following the intracerebral injection of DFP, time was given
to allow the DFP inhibited enzyme to age causing irreversible
inhibition and new AChE synthesis was studied at various intervals in various subcellular fractions.

As in vitro model

to study such a system, isolated synaptosomes (nerve-endings)
and microsomes from 20 and 58 dn,y old .rat brain previously
injected with DFP was chosen.

If AChE is transported from the cell body following its
synthesis at microsomes, there should be time lag following
DFP in the appearance of the enzyme at nerve endings as compared to the appearance in the microsomes of the cell body.
If the nerve endings synthesized their own AChE, AChE activity
in microsomes of the soma and in nerve endings

would appear

either simultaneously or it might be seen earlier at nerve
endings than in the microsomes.

Electron microscopy has

failed to reveal the presence of ribosomes within the axonal
and synaptic regions of neurons (Palay and Palade, 1955).
The axon contains no morphologically identifiable protein
synthesizing system.

The nerve terminals at the end of axons

are also devoid of identifiable ribosomes

RNA have been shown

to be present in the synaptosomal fraction (Austin and Morgan, 1967).

f
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Normally synaptosomes do not contain microsomes except as a
conta.ri1inant.

By making proper corrections, effect arising

due to this was eliminated.

Our data provide evidence for

the synthesis of AChE at nerve endings in 20 and 58 day old
rat brain following inhibition of the enzyme with DFP.

The effect of Triton X-100 on the nerve ending and microsomal AChE was also studied.

As the Triton X-100 released the

meinbrane-bound enzyme, this would give some results as to the
effect of DFP on the membrane-bound enzyme AChE.

The turnover of

rr~crosomal

and nerve ending AChE iso-

enzymes was studied following inhibition with DFP.

From the

percent of enzyme synthesized over a pierod of days following
DFP, the percent of enzyme turned over per day was calculated
(i.e. turnover rate).

The gel electrophoretic pattern of

isoenzymes following DFP was scanned and the individual isoenzyme value was compared against the scanned control value.
From these values, turnover rate of each isoenzyme was determined.

The isoenzymes may be localized in different cell

membrane and structures.

The turnover study would indicate

their localization and functional role of these molecular
species.
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In understanding studies of this nature, the misinterpreta-

tion of results due to various contaminants (from different
organelles) should be eliminated.

It is difficult to assess

for contamination as there are no specific markers for synaptosomes; however, contamination can be evaluated by studying
possible contaminating components of the preparation (cf. above)
the only contamination encountered was due to microsomes
(primary protein synthesizing machinery of the cell).

The

synaptosomes isolated at various time intervals were assayed
for NADPH dependent cytochrome C reductase (microsomal marker
enzyme) and corrections were made relative to this marker.

Another misinterpretation of the results might arise
because of the contamination of the synaptosomes by nonneuronal elements such as glial cells.

As glial cells con-

tain mostly cholinesterase, the values were corrected using
suitable inhibitors.

There is 20 percent contamination from membranes of
unkno-vm origin.

As results are obtained by comparing the

values with control group (prepared in a similar way to drug
treated group), the error due to membranes of unknown origin
was reduced

The difficulty in using Ficoll is its varia-

bility from batch to batch which varies depending upon the
ion concentration and particle flux.

To study ion flux, it

was necessary to remove the high salt content by dissolving
the Ficoll in a small arnount of water and reprecipitating it
from 95% ethanol.

The ethanol was removed by lyophilization

for prolonged periods of time.

In this case also, differences

were eliminated by comparing the values of drug treated animals
with those of control aniina.ls.

,
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MATERIALS AND METHODS:

Male Sprague Dawley derived rats, 16, 20 and 58 days
of age were used in these experiments.

All animals were bred

and raised at the appropriate facilities of the animal house
at Veterans A&ninistration Hospital, Hines, Illinois.

Diisopropyl phosphofluoridate (DF.P) was obtained from
Sigma Chemicals.

cl4 labelled DFP was obtained from New

England Nuclear Corporation (lpc/ljllllole).

Working standard

was prepared fresh in propylene glycol for each group of
injections.

In early experiments with c1 4 labelled DFP, 10/..1 DFP
containing 2pc was administered intracerebrally under ether
anasthesia to 20 day old rats.

A 10µ1 Hamilton microsyringe

filled with known volume of labelled DFP was injected at the
predetermined positions.
to a marked region

(i-

11

).

Each time the needle was inserted
Prior to all DFP injections, the

rats received 6mg/kg of atropine methylnitrate intraperitoneally.

At various time intervals, the rats were killed by decapitation.

A 103 homogenate of the brain was prepared in

0.32M sucrose in 25mM Tris, pH 7.5.

A known amount of homo-

genate was solubilized with a solubilizer (phase combining
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system,

PcsTm,

obtained from G.D. Searle and Co., Arlington

Heights, Illinois) and was transferred to a scintillation
vial containing l5ml solution of premix P (98% PPO 2:5
diphenyl oxazole + 2% PoPoP 1:4 bis - 2 (5 phenyloxazolyl)
Benzene).

Solution of premix P was made at a concentration

of 5gms/litre of toluene.

Premix P was purchased from

Packard Co., Desplaines, Illinois.

The amount of radio-

activity in the vials were determined

on a Packard Tricarb

liquid scintillation spectrometer model 3003.

Two aliquots

from the same fraction were used for AChE and protein determinations.

To determine the amount of radioactivity bound

to the protein, homogenate was precipitated with 5 vols. of
trichloracetic acid.
dissolved in NAOH.

After drying, the precipitate was
Toluene was added to solubilize the

precipitate and the resulting solution was transferred to
a vial containing 15 ml of premix P solution and radioactivity
was determined as described above.

When a dose of l.5mg/kg DFP was used, the inhibition
of AChE at various subcellular fractions was found to be
insufficient (cf. results, Table III).

A dose of 3.5mg/kg

was used in subsequent studies in 20 day old rats.

Control

animals were given propylene glycol intracerebrally; the volume
(lOpl) was identical to that employed for the injection of DFP.
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58 day old rats were anesthetized with pentobarbital
(20mg/kg) 30 minutes following i.p. administration of atropine methyl nitrate (6mg/kg).

Animals were held to the

stand with the help of strings and a longitudinal incision
was made dovm the center of the scalp.
blade,

sk~ll

Using a scalpel

was cleared of muscle and connective tissue.

With predetermined coordinates, a small hole was drilled
using a hand drill containing 1/32" drill bit.

lOp.l

Hamilton Microsyringe filled with DFP at a dose of 2mg/kg
were lowered through wax filled hole.

The needle was in-

serted to a depth indicated by a mark, DFP injected in the volume of the hole innnediately filled with bone wax and the skin
incision sutured with nylon.

No antibiotic was administered.

Similar surgical procedures were performed in control animals
w~ich

received propylene glycol instead of DFP.

Due to survi-

val problem, the dose of 2mg/kg of DFP was used rather than
3.5mg/kg.

Following the DFP injections, animals were sacri-

ficed at various intervals of time.

The cerebral hemispheres

were excised and bathed in 0.32M sucrose buffer prior to homogenization.

Excision was completed within 20 seconds follow-

ing sacrifice of the animal.

FRACTIONATION PROCEDURE:

The isolation of subcellular fractions.

What follows is a diagram of the general procedure of isolation of synaptosomes and microsomes (Autilio et al., 1968).

FLOW CHART FOR ISOLATION OF SUB-CELLULAR FRACTIONS
10% Homogenate (0.32M sucrose in 25mrn Tris adjusted to pH 7.5)
Centrifuge
lOOOxg for 10 minutes
r--~~~~1--~~~,

Pellet
Supernatant

washed with lOml of sucrose buffer
e-centrifuged at
OOOxg for 10 minutes

Supernatant + Supernatant
1
2

Pel et
(Nuclei, unbroken tissue fragment)

Combined Centrifuge
14,000xg for 15 minutes

Sup~rnatant
3

Pel~et

(Crude mitochondria)
(Resuspended in 0.32M sucrose in 25mrn Tris
adjusted to pH 7.5
Centrifuge
15,000xg for 20 minutes

Supernatant + Supernatant
3
4

Pellet (mitochondria)

Suspended in 0.32M sucrose in
Combines and
centrifuged
25mm Tris PH::.7.5.3ml/gm of
110,000xg for 75 minutes original tissue
(used for synaptosome isolation)
Supernatant

Pel et Microsomes This fraction was layered on
a Ficoll gradient

r
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The patterns of Ficoll gradient were as follows:
5 ml of mitochondria in 0.3211 sucrose in 25mm Tris (Pfr 7.5)
5 ml of 5% Ficoll in 0.32M sucrose in 25mm Tris

(pH 7. 5)

5 ml of 7.5% Ficoll in 0.32M sucrose in 25mm Tris (pH 7.5)
5 ml of 10% Ficoll in 0.32M sucrose in 25mm Tris

(pH 7. 5)

5 ml of 13% Ficoll in 0.32M sucrose in 25rnrn Tris

(pH 7. 5)

5 ml of 20% Ficoll in 0.32M sucrose in 25mm Tris

(pH 7. 5)

The crude mitochondrial fraction on a Ficoll gradient was
centrifuged at 25,000xg for 45 minutes in an IEC head SB-100.
Five layers were visible after centrifugation; myelin being
lighter was in the top layer and the denser mitochondria
formed the lower layers.

Synaptosomal fraction of inter-

mediate density was formed as two separate layers between
7.53 and 13% Ficoll.

As these two layers between 7.5% and

13% Ficoll represented a good source of nerve ending fraction (demonstrated by electron microscopy) they were pooled
and analyzed.

Synaptosomal layers were collected, diluted

in sucrose buffer and centrifuged at 40,000xg for 30 minutes.
The pellet obtained in the wash was rewashed in sucrose buffer
to remove Ficoll.

Each final pellet obtained from the various

fractions (microsomes, motochondria and synaptosomes) was
homogenized in sucrose buffer (0.4ml/g of original tissue)

•

and stored at -40 r until use.

A known a.mount of these

fractions were used for AChE assay, protein detennination,
electrophoretic separation, triton extraction and electron
microscopy.

r
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ELECTRON MICROSCOPY:
The synaptosomal pellets were fixed for electron
microscopy in 0.1.M phosphate buffered glutaraldehyde
(3.125%).

After overnight washing in 0.1.M phosphate,

the sample was osmicated for 1 hour in 1% buffered osmium
tetroxide in the dark, which was followed by dehydration in
35%, 50%, 70%,

80%, 95% and absolute ethanol (10 min. each)

at approximately

4•c.

The sample was allowed to stand in

propylene oxide for 20 minutes, in propylene oxide: Epon
resin l) (1:1) for 45 minutes, in propylene oxide: Epon
resin (1:3) for 45 minutes, epon for 1 hour and finally in
epon for 8 hours.

Finally, it was embedded in fresh epon

•

in electron microscopy capsules and heated at 65 C for

48-72 hours.

l) Epon employed for embedding had the following components:
16 volumesl Epon (Epon is a glycerol based aliphatic epoxy
resin of almost water white color and low viscosity.)
10 Volumes dodecenyl succinic anhydride.

9 volumes methyl nadic anhydride.
0.6 volumes dimethyl amino methyl phenol (DMP 30).
When Epon is cured with dodecenyl succinic anhydride, a
rather soft block

rt. sul ts,

whereas when cured with methyl

nadic anhydride and dimethyl amino methyl phenol, a very
hard block is formed.

To produce blocks of desired hard-

ness, various proportions of stock mixture was used.
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PROCEDURE FOR ELECTRON MICROSCOPY:
The Epon embedded pellets were sectioned with a Du Pont
diamond knife on the servall
MT-2.

Porter-Blu.~

ultra microtome

After the sections were placed on 300 mesh specimen

grids, they were stained with 103 ethanolic solution of uranyl
acetate and 0.28% of alkaline solution of lead citrate for
two minutes in each solution with several rinses in between.
Electron microscopic study was performed on RCA EMU-3H instrument.

TRITON X-100

E..~TRACTION:

Known amounts

(mg/ml)

of synaptosomal and microsomal

fractions were homogenized with equal volumes of 2% Triton in
sucrose buffer, thus making the final concentration to 1%
Triton.

Solutions were stored at 4•c for 6 hours and then

centrif'uged at 100,000xg for 30 minutes.
suspended in lm1

~O.

The sediment was

Supernatant and sediment were analyzed

for enzymatic activity.

ENZYMATIC ASSAYS:
Acetyl cholinesterase (AChE) assays were performed by
the method of Ellmann et al., (1961) using acetyl thiocholine
iodide (2.6mM) as ~ubstrate (Sigma Chemical Company).

The

enzyme activity is measured by following the increase of
yellow color produced from thiocholine when it reacts with
dithio-bis-nitrobenzoate ion.

It is based on coupling of

r
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the following reactions:
Acetyl Thiocholine Enzyme Thiocholine + acetate
Thiocholine + Dithiobisnitrobenzoate

~

yellow color.

The yellow color is measured in a spectrophotometer at 412mu.
The reaction with the thiol has been shown to be sufficiently
rapid so as not to be rate limiting in the measurement of
the enzyme and the concentrations used do not inhibit the
enzymic hydrolysis (Ellma.nn et al., 1961).

Corrections were

made :for non-enzymatic substrate hydr.olysis.
hydrolysis was obtained for first 10 minutes.

A linear rate of
The slope of

the curve expresses the rate in absorbance units/minute.
From the extinction coefficient o:f the yellow anion moles of
substrate hydrolyzed were detennined

Enzyme activity was

expressed as specific activity; specific activity is equivalent to umoles of acetyl thiocholine hydrolyzed per minute
per mg of protein.

Quinidine sulphate (1%) was added at the

beginning of the reaction to inhibit cholinesterase (Ellma.nn
et al. , 1961).

Cytochrome C reductase was

~ssayed

method of Sottocosa et al., (1967).

by the spectrometric

Essentially, the method

involves the measurement of the formation of reduced cytochrome
C in terms of the increase in optical density at 550m.u.
final concentration of cytochrome C was 1 mg

/ml. · Rate

The
was

linear for the :first minute and declined after 40% cytochrome
C was reduced.

Rate of cytochrome C reduction was calculated

f
from linear portion of the curve.

Increase in O.D. at 550mµ

per mg of protein per minute was used for calculating the activity

The protein was determined by the method of Lowry et al.,

(1951) using bovine serum albumin {Pentex, Kankakee, Ill.) as
standard.

ACRYIAMIDE GEL ELECTROPHORESIS:

When subjected to electrophoresis in acrylamide gels, a
complex misture of proteins divides up into number of well
defined zones or bands {Ornstein and Davies,

1964 ). Acryla-

mide gels have the great advantage of providing an uncharged
matrix in which separation based on molecular sieving and
mobility differences can be carried out.

The ability of

molecules to pass through a sieve depends on the size and
shape of the holes in the gel, the size and shape of the
molecules being sieved and interactions such as ion exchange
which may occur between the molecules and matrix of the gel.

Acrylamide gels used in these experiments are long
chain molecules with varying proportion of cross linkages
resulting from the addition of a proportion of bisacrylamide before polyme1ization.
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A set of three gels were used in the separation, the
sample, the spacer and the separating gel.

These three gels

provided a better separation of the sample.

In the case of

sample and spacer gel, the polymerization of acrylamide was
achieved by the addition of riboflavin.

Solution of acryla-

mide and riboflavin illuminated by an ultra violet light brought
about the gel formation.

Gels were formed after exposing the

solution (acryla.mide + riboflavin) to ultra violet light to a
pre-determined time.

In the case of separating gel, polymerization of acrylamide was brought about by the addition of ammonium persulphate.
The sample and spacer gel are characterized by a large pore
size and different buffer system as compared to the separating
gel with a small pore size.

The sample applied on the sample

gel concentrates sharply at the gel interface due to difference
in buffer system and pore size (between the separating and
sample gel).

After this process is completed, the concentrated

sample separates into the isoenzymes as they migrate through the
small pore gel.
it permits

The greatest advantage of this system is that

the concentration of the sample from a relatively

large volume.

PROCEDURE FOR POLYACRYLAMIDE GEL ELECTROPHORESIS:
Polyacryla.mide disc electrophoresis was performed in a
Canalco apparatus according to the method of Davies

(1964)
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as modified by Juul (1968) using glass tubes (I.D) 5nnn, length

68mm, containing

1ml of separating gel.

The composition of

the various gels are shown below.

SAMPLE GEL: (lOOml) consisted of 2.5gm acryla.mide, 0.25gm of
N.N. methylene bis acryla.mide, 0.063ml of N:N:N:tetramethylene
dia.mine,

20 gm of sucrose, 0.63

mg

of riboflavin, 6.3 ml of

IN HCl, and O. 69 gm of Tris hydro.xyamino methane.
the final solution was adjusted to

The pH of

pH~5.8.

SPACER GEL was identical in composition and pH with sample
gel, except that sucrose was added in the amount of 30 rather
than 20 gm.

SEPARATING GEL (lOOml) was made with 9 gm acryla.mide, 0.16 gm
N:N methylene bis acryla.mide, 0.03 ml N:N:N:N tetra.methylene
dia.mine, 10 gm sucrose, 0.075 gm ammonium persulfate, 6.3 ml
INHCl, and 3.75 gm tri-hydro.xy amino methane.

The pH of the

final solution was adjusted to 8.7.

All che,"11.icals for electrophoresis were from Canal Industries Corporation, Maryland.

The actual procedure for electrophoresis was as follows: ·

r
I
I
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The separating and spacer gel following polymerization were
kept at

4'c

for 20 hours.

The sample gel carrying ACbE-con-

taining sample (synaptosomes or microsomes) was polymerized
prior to electrophoresis.
applied to each gel.

Normally 50-75

Electrophoresis was performed at 3 ma

per column for 3 hours at
pH 8.0.

p.g of protein was

4• C using

Tris-glycine buffer at

The gels were recovered from each glass tube by ,

rinnning individual tube with a jet of water

After removal,

each gel was incubated for 30 minutes in 15 ml of l/15M phos-

.

phate buffer, pH=-6.l, containing O.OJJ.1 glycine, O.OOJJ.1 euso 4 ,
"

0.03M Na2so4 at 25 C.

Final incubation was performed in the

same buffer containing 3xl0-5M acetyl thiocholine iodide for

90 minutes.

Both preincubation and incubation solutions

included suitable inhibitors when required.

The inhibitor

was ambenonium mytelase; N:N'Bis, 3 diethylamine ethyl oxamide bis 2 chlorobenzyl chloride which inhibited ACbE at a
concentration of 5xl0-~; this inhibitor was used to differentiate the acetyl-and cholinesterases.

After the enzymic

reaction had proceeded sufficiently, the gels were then transferred into 3M

(NH4)2S04

saturated with dithioxamide to fix

the enzyme and were allowed to stand at

4c

for 24 hours.

Destaining was accomplished with 7% acetic acid.

The gels

containing the stai: ed isoenzymes of microsomes and synaptosomes were scanned in a Canalco model T microdensitometer
without a filter to determine relative distribution of ACbE
activity in the various isoenzymes.
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For heavier and weaker bands, the settings were 20 mm2
and

4 nnn2 per integration respectively.

established at anodal end.

The base line was

The percent of each peak was cal-

culated from the total integration of all peaks.

From the specific activity (AChE) of the applied sample
and from the percentage of each peak, relative specific activity of each isoenzyme band was calculated.

Microsomes and

synaptosomes from control and DFP treated rats were analyzed
for isoenzymes in this manner.

By

comparing the relative

specific activity of the isoenzymes of the control group
with that of DFP treated group {rats), the percent inhibitions
of microsomal and synaptosomal isoenzymes were calculated.
The relative rate of the return of enzyme activity of microsomal and synaptosomal isoenzyme with time was measured by
analyzing and comparing the values of various groups of DFP
treated rats with control rats.

By subjecting the values from

various animals to computer analysis, the standard error of
the mean was determined.

f
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RESULTS:
The purified rat brain synaptosomes or nerve endings
obtained by using a discontinuous Ficoll gradient are shown
in Figure 1.

Bands B and C represent a compact mass of in-

tact nerve endings.

The combined Band C fractions layered between 7.5 and

13% Ficoll in a Ficoll gradient represent the synaptosomal
or nerve ending fraction.

The combined

fractions were

analyzed by electron microscopy; a typical electron micrograph of these fractions is shown in Figure 2 and 3.

Synap-

tosomes can be expected to contain the organelles present
presynaptically (intraterminal mitochondria and vesicles)
and their post synaptic attachments.

As demonstrated by

electron microscopy our synaptosomal fractions were found to
be relatively pure; in most cases, the intact synaptosomes
with their vesicles, intraterminal mitochondria and post junctional complexes could be seen.

Dark, ill defined fragments

were also present; according to many investigators (cf. for
instance De Robertis et al., (1963)) these fragments are the
so-called synaptosomal ghosts and represent the synaptosomal
junctions.

This specialized junction associated with its

organelles and particularly with the clumped presynaptic
vesicles has been called by Palay (1958) "The synaptic
complex".

There is no direct evidence to prove that the

FIGURE 1

Final stage of purification of 20 day old rat
brain synaptosomes:

the discontinuous Ficoll

gradient, synaptosomal fraction sediments between

7.5% and 13% Ficoll.
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Figure 2:

Electron Micrograph of 20 day old rat brain
Synaptosomal preparation 44,900 x magnification.
1.

Synaptic vesicles

2.

Large vesicles

3.

Coiled elongated mitochondria

4.

Dark Fragments (Junctional complex)
Specimen fixed in glutaralde.byde and OS04 as
described in methods.
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Figure 3:

Electron Micrographs of 20 day old rat brain
synaptosomal preparation.

80,820 x magnification.
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synaptic complex corresponds to the site where chemical transmission takes place.

This conclusion can be however extra-

polated from neurophysiological studies of intact synapses;
moreover, indirect evidence indicates that the synaptic complexes are the specialized zones

of the neuronal membrane

where the neurotransmitter is released at the presynaptic site
and where the substance exerts the effects at the post synaptic site.

Figure 3 represents the electron micrograph of the

synaptosomal fraction under hipher magnification.

The elong-

ated mitochondria, vesicles and post-synaptic attachment can
be seen at higher magnification.

STUDIES USING (c

14

)-IABELLED DFP:

Initially it was intended to study the binding of (c

14

)-

DFP to various subcellular fractions and the turnover of radioactivity at various intervals of time.

For this purpose, DFP

was administered by intracerebral injection so as to avoid its
accumulation in fat depot which would occur following peripheral
(i.v. or s.c.) administration.

In the initial experiments,

varying amounts of (c14)-DFP (l)lc/lumole) were injected intracerebrally in 20 day old rats.

The animals were sacrificed

24 hours following the injection. A 10% homogenate of the
rat brain in 0.32M sucrose buffer was made
ute per total homogenate were determined.

Cou~ts

per min-

As can be seen in

Table I, the radioactivity of the rat brain homogenate was
increased with increasing a.mount of labelled compound
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RECOVERY OF RADIOACTNITY IN THE RAT BRAIN HOfv40GENATE
FOLLOWING INTRACEREBRAL INJECTION OF cl DFP
Amount of
cl4DFP used

Number of
rats

Time of sacrifice
following the
in_jection

Counts per minute
per total
homogenate

@2. OJ.tc

3

3 hours

63, 720±2580

©I.4Jf

3

24 hours

41, 985±2095

@0. 8JfC

6

24 hours

19, 760±720

6

24 hours

22, 270±1020

@)0. 4J.JC

4

24 hours

11, 340±450

@o.lJ.tc

3

24 hours

l, 708±100

counts in
the liver

Table I:

Varying amounts of Cl4DFP were injected by intracerebral injection.

Animals were sacrificed at

various time intervals.

' 77
(1708 cpm for O.lrc to 41985 cpm for l.lipc).
were .also determined

Total counts

in the liver in one set of experiment,

the purpose of which will be discussed later.

The recovery of radioactivity in the homogenate follow14
ing the injection of (c )-DFP could be calculated from the
values in Table I.

The recovery of radioactivity was approxi-

mately 1% following various injections.
W3re made to improve the recovery.

Various attempts

14
(c )-DFP used in the

experiment depicted in Table I was prepared in propylene glycol, emulsions were prepared in a number of different media
so as to facilitate better binding of (c

14

)-DFP.

The media

used were peanut oil, saline (0.9%), albumin (10%) and unlabelled DFP (6oµg).

Varying amounts of (c

14

)-DFP were

mixed with 10µ1 of the media described above and injected
intracerebrally into 20-day old rats.
24 hours following the injection.

Rats were sacrificed

Counts per minute in the

total homogenate were determined (Table II).

The percent

recovery of radioactivity using various media were as follows:
1
(c 4)-DFP in propylene glycol 1.0% (calculated from the values
in Table I) with unlabelled DFP 0.000193, peanut oil 0.00054%,
saline 0.0023% and albumin 0.00933.
unlabelled DFP or

r·~anut

It can be seen that using

oil as a media reduced the recovery

of counts in the homogenate following the injection.
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EFFECT OF VARIOUS CARRIERS USED WITH c 14 DFP IN THE
RECOVERY OF RADIOACTIVITY FOLLOWING INTRACEREBRAL
INJECTIONS
A:'Aount of
C DFP used

Time of
Sacrifice

Carrier

Counts per minute
in total homogenate

1. 8J.te (6)

Unlabelled DFP

24 hrs.

7690 ± 1200

1. 7J.JC (3)

Peanut oil

24 hrs.

2028 ± 200

1. 4).JC ( 3)

Saline

24 hrs.

7326 ± 800

1. OJJC (3)

Albumin

24 hrs.

Table II:

c14

20, 472 ± 2000

DFP was injected intracerebrally with various

carriers.

Rats were sacrificed 24 hours

the injection.

Counts per minute in total homogen-

ate was determined.

Number in parenthesis indicates

the number of animals used.
as mean + S.E.M.

following

Values are expressed
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It was critical at this point to examine the distribution of (c14 )-DFP (l.Opc) in the various subcellular fractions
following the injections.

Twenty-four hours following the

injection, rats were sacrificed, brains from three experiments were pooled and a 10% homogenate in sucrose buffer
was made.

Subcellular fractions were obtained from the

homogenate by differential centrif'ugation. Distribution
14
.
of (C )-DFP with respect to total homogenate was determined.

As can be seen in Table III microsomes, mitochondria

and nerve endings carried 1.12, 1.07 and 0.004 percent of the
counts respectively.

The rest about 98% of the count was

found in nuclear and soluble fractions.

To ascertain the

nature qf these counts and whether they were protein bound
or not, these fractions were precipitated with TCA.

Micro-

somal TCA precipitate exhibited 13% of the original counts
'Whereas mitochondrial TCA precipitate exhibited 13% of the
original counts

whereas mitochondrial TCA precipitate ex-

hibited 23% of the original mitochondrial counts.

We further explored the poor recovery problem, by
analyzing the various subcellular fractions electrophoretically.
buffer.

Isoenzymes were cut from the gel and extracted with
Counts per minute per each isoenzyme band were

found to be few in numbers (approximately 20 cpm per band).
It was clear from these results that DFP of higher specific
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PERCENT DISTRIBUTION OF c 14 IN VARIOUS SUBCELLULA
FRACTIONS FOLLOWING INTRACEREBRAL INJECTION OF
cl4 DFP

percent compared to total homogenate
1.12%

Microsomes
Mitochondria

1. 07%

Nerve endings

o. 004%

Nuclear Fraction

Table III:

29. 3%

·14

Following C DFP injection, brains were pooled.
Various subcellular fractions were isolated following differential centrifugation.

Total counts

in various fractions were calculated against the
total count in the homogenate and percent distribution was calculated.

,
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activity was needed to provide greater absolute recovery
and data needed for subsequent experiments.

As we could

not obtain DFP of the high specific activity needed and thus
the problem of recovering sufficient counts appeared insoluble, our initial experimental design was altered.

Initially, it was intended to study the loss of radioactivity at various intervals in microsomal and in nerve
14
ending fraction following (c )-DFP injection.

It was also

intended to study the loss of radioactivity in various microsomal and nerve ending isoenzymes.

Loss of radioactivity of

microsomal and nerve ending fraction at various intervals
would give an indication of the disappearance of (c14 )-DFP
or the new synthesis of AChE.

14
(c )-DFP was employed in

these experiments at a pharmacological inactive dose, so
that inhibition sufficient to establish the new synthesis
was not produced.

Our subsequent plan was therefore to use

a high dose of non-labelled DFP and produce sufficient
inhibition of AChE in various subcellular fractions.

INHIBITION OF RAT BRAIN AChE BY DI-ISOPROPYLFLUOROPHOSPHA'IE

IN VITRO:
To estimate the dose of DFP needed to obtain the
necessary inhibition, preliminary studies were carried out
in vitro with rat brain homogenate.

Equal amounts (5 ml) of
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rA.t brain (20 day old) homogenate (1:10) were incubated with
various concentrations (l0- 3M to l0- 8M) of DFP in propylene
glycol for an hour at room temperature (Figure 4).

AChE

activity was determined at the end of the incubation.

Per-

cent inhibition of AChE was determined from the enzyme activity
of control incubated with propylene glycol.
linear for the io-~

-

The curve was

10-7M concentrations; l0-5M concentration

induced almost complete inhibition (92%) and not much additional inhibition was obtained with higher concentrations.

The in vitro inhibition of rat brain AChE was analyzed
electrophoretically (Figure 5).

The normal AChE isoenzyme

pattern of control homogenate is shown in A.

Four isoenzymes

were found in the control homogenate following incubation
with the substrate (acetyl thiocholine iodide).

-6

centration of 10 M DFP, Band

At a con-

4 was inhibited partially and

a small amount of AChE was found in the region of Band 2.
Bands 3 and 1 were inhibited almost completely.

At the con-

centration of 10-5M, the isoenzymes were almost completely
inhibited except for the presence of a light band at region

4.

-4

-3

The concentrations of 10 M and 10 M caused complete

inhibition of all the molecular species of the homogenate
(Figure 5).

5

These results indicated that a l0- M concentration

of DFP causes a 92% inhibition of the AChE of the rat brain
homogenate and almost a complete inhibition of the four iso-

r

THE INHIBITION OF RAT BRAIN AchE BY
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Figure

4: Equal amounts of rat brain homogenates were
incubated with various concentrations of DFP for
an hour at room temperature.
was determined from the

enzyr~e

control, incubated similarly.

Percent inhibition
activity of the

F
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·~

)

I

·B

A

Figure 5:

Set A:
Set B:
Set C:
Set D:
Set E:
Set F:

c

D

E

Acrylamide gel electrophoretic pattern of rat
brain AChE, when the homogenate was incubated with
DFP in vitro. Conditions were the same as described
for Figure 4.
Gel 1 - Control homogenate incubated with substrate
Gel 2 - Incubated with substr~te and myetalase
Homogenate incubated with 10-~ DFP. In all cases
1st gel was incubated with substrate, 2nd gel with
substrate and ambenonium (Myt~lase).
Homogenate incubated with io- M DFP
Homogenate incubated with 10- 4M DFP
Homogenate incubated with lo-3M DFP
All incubations were carried out at room temperature
for an hour.
Homogenate incubated ~tlth io-3M DFP for 4 hours at
room temperature.

F

enzymes separated electrophoretically.

IN VIVO INHIBITION OF RAT BRAIN AChE BY DFP:
In vitro, lo-5M DFP caused 92% inhibition of rat brain
AChE.

We chose a dose that by calculation - in terms of equi-

distribution of DFP - provided three times this concentration
as the lower dose for the in vivo studies (l.5mg/kg).

Twenty-

day old rats were injected intracerebrally with various doses
(l.5 - 4.0mg/kg) of DFP.
sacrificed.

Four hours later, the animals were

AChE activity was determined in the 10% homogenate.

Percent inhibition was determined from the enzyme activity of
control an.imal injected intracerebrally with propylene glycol.
As

sho~m

in Figure 6, inhibition varied from 76% at l.5mg/kg

to 95% at 4.0mg/kg.

In vivo, l20Jlg of DFP (4.0mg/kg) was required to inhibit
95% of brain AChE in a rat with an average weight of 30gms.
In vitro, l8.4µg of DFP (l0- 5M) inhibited 92% of brain AChE
in a lOml brain homogenate (equivalent to l brain).

These

results show that to inhibit the enzyme in vivo, six times
the in vitro concentration of DFP is needed.

These results

indicate the difficulties involved in inhibiting the AChE in
vivo following injections at various doses.

THE EFFECT OF DFP (l. 5mg/kg) ON MICROSOMAL AND SYNAPTOSOMAL
. AChE IN l6-:00.Y OLD RATS:

p
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20-day old rats were injected with various doses
of DFP intracerebrally.

Four hours following the

injection, animals were sacrificed.

loo/o brain homo-

genate in 0.32M sucrose (in 25mM Tris pH 7,5) was
made and analyzed for AChE.

Percent inhibition

was determined from the enzyme activity of control
animal injected in a similar kind of injection with
propylene glycol.

Values are expressed

(Three experiments, 6 rats).

~

S.E M.
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THE EFFECT OF DFP (l.5mg/kg) ON MICROSOMAL AND SYNAPTOSOMAL
AChE IN 16-DAY OLD RATS:
The inhibition found with homogenates in vitro following
incubation with DFP, does not indicate the degree of inhibition
in the various subcellular fractions, so a series of experiments
to determine this was carried out.
propylene glycol.

Control animals received

AChE specific activity of various subcellu-

lar fractions of control and DFP treated rats was determined
at various intervals of time.

Table 4 lists the specific activity of AChE of microsomal and nerve ending fractions of control and DFP treated
rats at various intervals following the injection.

From the

specific activity of control animals, the percent inhibition

was

calculated for the various intervals after the DFP injec-

~ion.

The nerve ending and microsomal AChE were inhibited

33.4 and 54.6 percent respectively 4 hours following the administration of DFP.

Twenty-two days following the injection,

i.e. in 38-day old rats {Table IV), the percent inhibition
in nerve ending and microsomal enzyme was reduced to 1. 6 and
32.3 percent respectively.

As DFP causes irreversible inhibi-

tion of AChE, the enzymatic activity after DFP treatment
could be accomplished only by the synthesis of new AChE.
This percent activity thus represents the amount of newly
synthesized AChE.

Thus, for a period of 22 days, AChE ac-

tivity was found to be increased by 31.8% and 22.3% of nerve
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ACETYL CHOLINESTERASE ACTIVITY OF MICROSOMES AND SYNAPTOSOMES IN CONTROL
AND DFP (1. 5mg/kg) TREATED 16-DAY OLD RAT FOLLOWING INTRACEREBRAL INJECTIONS
CONTROL
Synaptosomes
Microsomes
(~p. activity) (sp. activity)

DFP TREATED GROUP
Synaptosomes
Days atter Number Microsomes
(sp. activity) (sp. activity)
of rats
injection

Age of
the rat

Numoer
of rats

16

4

O. ll02

o. 090

1

4

0.050

0.060

23

4

0.146

0.103

7

4

0.106

0.095

31

4

0.188

0.124

15

4

0.120

0.115

38

4

0.192

0.128

22

4

0.130

0.126

Table

IV:

Sixteen-day old rats were injected with DFP
(l-5mg/kg) intracerebrally and sacrificed at
various time intervals.

Acetylcholinesterase

activity was determined in synaptosomes and
microsomes which were obtained by differential
centri:f'ugation as described in the text.

Specific activity is expressed as micromoles of
acetylthiocholine iodide hydrolyzed /min/mg
protein.
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endings and microsomes respectively over the initial
inhibition.

4

hour

As the recovery of synaptosornal enz;yme activity

was faster than that of microsomal enzyme, it follows that
nerve ending synthesis of AChE following DFP occurred faster
than the microsor.ial synthesis.

As shovm in the above experiment, the inhibition of
subcellular fraction with a dose of l.5mg/kg was incomplete.
This may have been due to several reasons, most likely to
the multiple binding of DFP to various proteins other than
AChE and proteolipids.

It was decided therefore to saturate

the system with a higher dose, so that a better inhibition of
subcellular fraction could be obtained.

In the pertinent set of experiments, a dose of 3.5mg/kg
was administered through the intracerebral routes.

Control

rats were given appropriate volume of propylene glycol intracerebrally.

Both control and DFP treated rats were sacrificed

at various intervals of time.

Specific activity of AChE in

various subcellular fraction was determined·

Table V summar-

izes the microsomal and nerve ending specific activity of AChE
of control and DFP treated rats at various intervals of time.
The percent enzyme (AChE) inhibition of DFP treated rats was
determined on various days with respect to the enzyme activity
of control rats obtained on the same days.

On the day of its

90

REGENERATION OF ACETYLCHOLINESTERASE IN SUBCELLULAR FRACTIONS OF RAT BRAIN
FOLLOWING INHIBITION OF THE ENZYME BY DFP (3. 5 mg/kg) INJECTED INTRACEREBRALLY
IN 20 DAY OLD RATS
CONTROL

DFP TREATED GROUP

Age of
the rat

Number
of rats

Microsomes
(sp. activity
± S.E.M)

Synaptosomes
(sp. activity
± S.E.M)

20

6

0. 109±0. 002

0.0986±0.001

23

6

0.145±0. 003

0.1027±0. 001

25

6

0.187±0. 005

35

6

0. 190±0. 004

Table V:

Days
after
injection

Number
of rats

Microsomes
(sp. activity
± S.E.M)

Synaptosomes
(sp. activity
± S.E.M)

6

0.0263±0.0001

0.0399±0.0002

3

6

0.0618±0.0005

0.0478±0.0004

0.122±0. 002

5

6

0. 0974±0. 001

0.0864±0.0008

0.120±0. 002

15

6

0.125±0. 003

0.104±0. 002

20-day old rats were injected with DFP (3.5 mg/kg)
intracerebrally and sacrificed at various time
intervals after treatment with DFP.

Control rats

received propylene glycol.
Subcellular fractions of brain were obtained by
differential centrifugation and assayed for Acetylcholinesterase activity.
gpecific activity is expressed as defined in Table IV.

91
ad.l"fiinistration

(4

hours follovring injection), DFP caused an

initial inhibition of 76 and 60 percent in the microsomal and
nerve ending AChE activity respectively.

With time (15 days),

the enzymic inhibition in microsomes and in nerve ending was

34.0%

reduced to

and

13.0%

respectively.

Thus, after a period

of 15 days, AChE activity was found to be increased by 47.C/1/o
and

42.03

of nerve endings and microsomes respectively over

the initial

4 hour

inhibition value.

Again, this reduction

in inhibition could be accomplished only by new synthesis of
the enzyme.

Synthesis of nerve ending AChE versus microsomal AChE
following DFP is shown in Figure

7. In this figure, the en-

zyme activity in various subcellular fractions following treatment with DFP was plotted against time.

For each day, the

percent of new synthesis was determined in the DFP treated
rats from the AChE activity of control rats determined on the
same day.

It is clear from Figure 7 that the recovery of en-

zyme activity in nerve ending fraction was always higher than
the recovery in microsomal fractions

In the course of the above experiments, DFP was given
during the period of rapid growth (myelin fo:nnation) at which
time the enzymes are being formed rapidly.

It was critical

to differentiate the new AChE that occurs in normal growth

RECOVERY OF ACETYL CHOLINESTERASE IN SUBCELLULAR
FRACTIONS FOLLOWING INTRACEREBRAL INJECTION OF
DFP (3.5 MG I KG) IN 20-DAY-OLD RATS
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DAYS

8

9

10

II

12

13

14

15

20-day old rats were injected with DFP'at a dose
of 3.5rog/kg.

After decapitation, subcellular frac-

tions were isolated from the cerebral cortex at
various intervals of time by differential centrif'ugation.

Percentage of enzyme activity in microsomes

and nerve endings representing the new AC.hE synthesis
were determined on the basis of AC.hE activity of
fractions from control rats isolated at similar
time periods.
activity

4

The first point shows the enzyme

hours following DFP.

in Table V.)

(Values with S.E.M
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from the AChE which is replacing the old inhibited AChE.
The enzyme activity arising due to normal development was
determined from AChE values of control rats (Table V).

The

values for AChE following DFP was corrected on the basis of the
developmental data and the results are presented graphically
in Figure 8.

In this case the developmental AChE increment

was subtracted from the enzyme activity of DFP treated rats
at various intervals of time and the difference represents
AChE synthesized to replace specifically the DFP inhibited
AChE.

As already stated, in 20-day old rats, DFP caused on

the day of injection, an inhibition of 76% in the microsomal
AChE activity as compared to control;

a~er

15 days, inhibi-

tion was reduced to 34% as a result of replacement by newly
synthesized AChE.

For a period of 15 days, therefore, the new

sy.µthesis of AChE in microsomes constituted 42% of normal
values; finally, after correcting this latter figure for the
ontogenic synthesis of AChE, the amount of AChE synthesized
for a period of 15 days to replace the inhibited enzyme was
16%

± 2%

(Figure 8).

Analogous data for the synaptosomal AChE was as follows:
DFP caused an initial inhibition of 6cYfo in the nerve ending
AChE activity four

ho~rs

following the injection; 15 days

later, the enzymic activity was only 13% inhibited as com-

RECOVERY OF AchE ACTIVITY AFTER INTRACEREBRAL DFP
ADMINISTRATION (3.5mg/Kg) IN 20-DAY RATS. VALUES ARE
CORRECTED FOR NORMAL DEVELOPMENTAL RATE.
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6

4

AFTER

10

12

14

INJECTION

Conditions as described in Figure 7 .

To differ-

entiate the synthesis of enzyme arising due to
normal development and the one arising due to
inhibition with DFP.

Corrections for normal

developmental rise were made in the DFP treated
rats and the initial point was extrapolated to
Zero.

16
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pared to controls {cf. Table V).

After the corrections for

normal developmental synthesis was made, it appeared that
during a period of 15 days the synthesis of AChE arising to
replace the DFP inhibited enzyme was
(Figure 8).

43% of the control values

Two pools of AChE were formed in DFP treated rats;

one was developmental enzyme, another the enzyme synthesized

to replace inhibited AChE.

In control rats, only one pool of

enzyme, that is the developmental AChE is being synthesized.
As the two groups of rats were of same age, the increase in
AChE synthesis in DFP treated rats seems to be related to the
inhibition of AChE by DFP.

This inhibition caused by DFP

might have repressed the feedback inhibition, normally due to
the accumulation of AChE thus resulting in an increased AChE
synthesis.

This increase may be regulated either at the nuclear

or at the microsomal level.

There could be an increase in the

production of niRNA or protein.

The increase in AChE in DFP

treated rats might represent the developmental enzyme.

At

this point with results available, we are not able to distinguish clearly as to which pool of enzyme activity was increased.

Altogether, whether corrected for normal development or
not, the nerve endings showed higher percent of AChE synthesis
as compared to microsomes following DFP treatment (Compare
Figures 7 and 8); in fact, the corrected figure shows a more
rapid rate of AChE synthesis in the synaptosomes as compared to
microsomes.

CHARACTERISTICS OF THE EFFECT OF PFP IN OLDER RATS (58

d.a.y):

Various workers have demonstrated that protein synthesis
occurs in isolated synaptosomal preparations.

Austin and Mor-

gan (1967) studying protein synthesis in synaptosomes showed
the rate of incorporation of (c14 )-leucine as linear and
decreased with the age of the rat (cf. Introduction).

The

question arises as to whether the nerve ending synthesis is
associated with the normal development of the animal and
ceases at maturity or is a phenomenon which occurs in all
age groups.

It seemed appropriate therefore to compare the

synthesis of AChE after DFP in the nerve ending of older
animals.
study.

A group of 58 day old rats were used for this
As it was difficult to keep the older rats alive

after the higher dose (3.5 mg/kg) of DFP, a dose of only
2 mg/kg was given via the intracerebral routes.

Control

rats received intracerebrally the appropriate volume of
propylene glycol.

Rats were sacrificed at various inter-

vals of time following the administration of DFP or propylene
glycol.

The specific AChE activities of the microsomal and

nerve ending fraction of the brains of both the experimental and control rats were obtained on days 1,5,11 and 20
and AChE activity expressed as percent of controls.
shows AChE activity of microsomes

Figure 9

and nerve endings as com-

pared to control values on days 1-20 following DFP administration.

As can be seen, 80% of microsomal AChE and 86% of

the nerve ending AChE was inhibited on the day of injection.
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RECOVERY OF ACETYL CHOLINESTERASE IN SUBCELLULAR
FRACTIONS FOLLOWING INTRACEREBRAL INJECTION OF
DFP (2.0 MG/KG) IN 58 DAY OLD RATS
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58-day old rats were injected with DFP (2.0

mg/kg)

intracerebrally and killed at various intervals of
time following the injection.

Subcellular fractions

were obtained by differential centrifugation and
assayed for AChE.

Percentage enzyme activity

representing the new synthesis was determined from
enzyme activity of control animal injected with
propylene glycol.

Each point in the curve repre-

sents the value obtained from 6 rats
expressed as

~

S.E.M.

Values are

20

r
Twenty-two percent of nerve ending AChE and 35% of microsomal
AChE remained inhibited on day 20

a~ter

DFP; as compared to

normal values, 45% of the inhibited microsomal enzyme and 64%
of the inhibited nerve ending enzyme was replaced by newly
synthesized AChE.

As in the case of younger animals, at all

intervals after the administration of DFP the nerve endings
always showed higher percent of replacement of the inhibited
enzyme when compared to microsomes, and particularly between
days 1 and

4,

AChE of the nerve ending fraction showed a more

rapid rate of synthesis as compared to microsomal AChE.

The recovery of AChE following DFP injection was more
rapid in 58 day than in 20 day old rats.
day old rate,

In the case of 20

47.0 and 42% of DFP inhibited enzyme was re-

placed by newly synthesized AChE at the nerve ending and at
the"microsomes, respectively, after a period of 15 days.
In the case of

58 day old rats, 64 and 45% of the DFP-inhib-

ited enzyme was replaced at the nerve endings and at the
microsomes, respectively, during the same time period.
(Figures 7 and 9, Table V).

Furthermore, in 58 day old rats DFP caused on the day
of injection an 80% inhibition of microsomal AChE and 86% inhibition of the nerve endings enzyme, whereas in 20 day old rats
DFP caused an inhibition of 76 and 60% inhibition in microsomes and nerve endings, respectively.

Due to the constant

need for AChE, particularly in the adult, marked inhibition
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might alter the synthesizing mechanism resulting in a rapid
synthesis.

Except on the day of injection, in both age groups,

the nerve endings always showed higher percent of enzyme recovery when compared to microsomes.

The faster rate of nerve

ending AChE synthesis following DFP inhibition both in young
and older rats demonstrates that at least a fraction of AChE
synthesis at the nerve endings is not an age dependent phenomenon.

EF'FECT OF TRITON ON AChE:
As AChE is a membrane bound enzyme, various procedures
must be used to solubilize the enzyme.

If the enzyme is

bound in such a way that its active centers are directly
available to substrate, then permeability limitations with
respect to DFP and substrate will not apply.

However, as

the enzyme is present in intact organelles (microsomes,
synaptic cleft), permeability limitations will be evident
if the active center of the enzyme resides within such
structures.

To ensure that the substrate is available to

the active site, we decided to solubilize the enzyme, with
non-ionic detergent Triton X-100.

Preliminary studies of the effect of Triton X-100 were
conducted on human brain AChE.

2 gm of human brain was

homogenized with 4 vols. of extraction media
Triton X-100

(0.2-5.03)

in

o.9%

(0.9%

saline solution).

NaCl or
Following
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centrifugation, supernatant and sediment was analyzed for
AChE activity and values obtained with and without Triton X100 were compared.

Effect of various concentrations of Triton

X-100 on the human brain AChE activity is shown in Table VI.
There is redistribution of protein between supernatant and
sediment, and solubilization of more than 50% of the protein
when the concentration of the Triton X-100 is increased from
0 to

5.oo/o.

Despite the loss of protein in the residue, the

total AChE activity remains virtually constant in the residue
at Triton X-100 levels of 0.2 to 2% and only at 5% level does
some inhibition of activity appears to occur.

"Relative"

specific activity was expressed as the specific activity which
was arbitrarily set at 100.

At 1% Triton X-100 levels, the

relative specific activity value of the supernatant was increased to 36o, with little change in relative specific
activity of the residue.

At 2.0% and 5% Triton X-100 con-

centration, the relative specific activities were 230 and 120,
respectively.

Without a conconunitant loss of enzyme activity

in the residue, the increase in supernatant enzyme activity
indicates the activation by Triton X-100 of AChE or release
of bound AChE which was not normally available to the substrate.
There was also an increase in the total enzyme activity.

It was important to rule out that the effect (increase
in AChE) observed by Triton X-100 was not due to the effect
of Triton X-100 on the enzyme substrate reaction rather than
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EFFECT OF TRITON X-100 ON •

0.9%
X-100
X-100
X-100
X-100
X-100

Total protein ( mg)

Volume of
sample (ml)

Extractive

Saline
Triton
Triton
Triton
Triton
Triton

BRAlN ACETYLCHOLINESTERASE ACTIVITY

0. 2%
0. 5%
1. 0%
2. 0%
5. 0%

Total enzyme
activity (units}*

Relative

spec. act:

**

Total enzyme
activity (units)

Residue

Supernatant

Residue

Supernatant

Residue

Supernatant

Residue

Supernatant

Supernatant + residue

13. 4
13. 2
13. 3
13. 0
14. 3
14.2

9. 5
9.6
9.2
8.6
8.9
8. 8

154. 2
150. 5
148. 9
126. 0
127. 2
78.1

23. 7
36. 5
43. 2
67. 0
82. 7
113. 5

2. 0
2. 0
2. 0
1. 9
2.1
1. 4

0. 30
0. 98
1.19
2.18
1. 94
1. 36

100
93
87
93
106
106

100
260
280
360
230
120

2. 30
2. 98
3.19
4. 08
4. 04
2. 76

*µmoles acetylthiocholine iodide hydrolyzed/min per ml solution.
**Saline values arbitrarily set at 100 where spec. act. = moles acetylthiocholine iodide hydrolyzed/ min per mg protein.

Table VI:

Human brain, 2 gm, was homogenized with

4 vol.

of extraction media (0.9"/o NaCl or the appropriate
Triton X-100 concentration )0.2-5.0%) in a saline
solution) and incubated for 30 minutes at 4*c and
centrif'uged at 100,000xg for 1 hour.
ment was dissolved in 12 ml of water.

The sediThe super-

natant and sediment were analyzed for AChE activity
as described in Methods.
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to the solubilization of the enzyme.

The effect of Triton

X-100 on the ACbE assay system therefore was studied.
system contained soluble saline-extracted enzyme.

This

Various

concentrations of Triton X-100 were added to the reaction
mediur.i, containing saline extract of human brain ACbE and
acetyl thiocholine iodide.

With various concentrations of

Triton X-100 in the enzyme-substrate medium neither the
residue nor the supernatant showed any significant changes
in ACbE activity.

The specific

acti~ity

of the residue and

supernatant were approximately 2.0 and 1.0 respectively at
all detergent (Triton X-100) concentrations.
X-100 per

~

does not appear to have

Thus, Triton

any effect on enzymic

activity after the enzyme is extracted. (Table VII)

The activation of ACbE brought about by Triton X-100 ·
may be due to the release of the enzyme from its association
with membrane fragments in varying degree or to the unmasking
of the hidden catalytic sites.

It is possible that Triton

X-100 may open up active sites which are not normally available for substrate and are hidden in the membranes.

EFFECT OF TRITON X-100 ON THE DFP INHIBITED ACbE:
With the background of information obtainer. as to the
effect of Triton X-100 on human brain ACbE, we decided to
study the effect of Triton X-100 on the DFP-inhibited enzyme.

The purpose was to examine the effect of DFP on the
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EFFECT OF TRITON X-100 ON ACETYLCHOLINESTERASE ASSAY VALUES
Residue

Supernatant
Spec.
act.
(xlO 2 )

Sample
Saline residue
+ 0. 2% Triton
+ 0. 5% Triton
+ 1. 0% Triton
+ 2. 0% Triton
+ 5. 0% Triton

2. 0

X-100
X-100
X-100
X-100
X-100

1. 9

2.1
2.2
2. 2
2. 2

Spec.
act.
(xlO 2 )

Sample
Saline extract
+ 0. 2% Triton
+ O. 5% Triton
+ 1.0% Triton
+ 2. 0% Triton
+ 5. 0% Triton

X-100
X-100
X-100
X-100
X-100

1. 0
1. 0
1. 0
1.1
1.1
1.1

Specific activity is expressed as µmoles acetylthiocholine iodide hydrolyzed/ min per mg protein.
Residue contained· 7. 4 mg protein I ml. Supernatant contained 3. 4 mg protein I ml.

Table VII:

Conditions as described in Table VI.

Various

concentrations of Triton X-100 was added to the
assay medium and values were compared to the
control without Triton X-100.

r
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membrane bound or Triton-extractable enzyme.

By

studying

the effect of Triton X-100 on the DFP-inhibited enzyme, the presence of hidden or bound catalytic site would be revealed.

Subcellular fractions from the brain of DFP (3,5 mg/kg)
treated and control rats (20 day old) at a protein concentration
of 1 mg/ml were homogenized with and without 1% Triton X-100.
The supernatant and sediment obtained following centrif'ugation
was analyzed for AChE activity.

The combined specific activity

of supernatant and sediment represents the total enzyme activity.
The enzyme activity determined in the absence of Triton X-100
represents the soluble AChE.

The difference in amount between

the total and the soluble enzyme activity represents enzyme
released by Triton X-100, i.e. the bound enzyme.

The per cent

recovery at various times following DFP of the total enzyme
activity of various subcellular fractions of brains of rats
injected with DFP was determined with respect to the total
enzyme activity of the control rat brains.
culated from the values in figure 10 that

It could be cal-

4 hours after the

inhibition of the total enzyme activity of the nerve ending
was 51% while the inhibition of the soluble synaptosomal
enzyme was

6o%.

Fifteen days following the injection, the

inhibition of the total enzyme activity was 1% while the
inhibition of soluble AChE was 13.0%.
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E.FFECT OF TRITON X-100 ON Tl-£ RECOVERY OF ENZYMf ACJIVITY
(AchE) IN SUBCELLULAR FRACTIONS AFTER 1.C. INJECTIONS
OF 3.5mg/Kg OFP

9'

f

-----------------1

>-

~ 80

1,.....-

~

~ 64

I-

z

I

48

w
u

a:

~

,
/
A ,,1--_.,__. ...-· --·
~

~
zw

,

T',

,.-.--

------1

--·---·

----z:

,_..y

,,-}/·

!' /•
32

----------=-·-·-·...Z
-------

0

Triton treated DFP nerve endings

/

---

DFP nerve endings

.A

----

Triton treated DFP microsomes

"

- · - DFP microsomes

16

o,.......~~-r-~--,....-~...,.~~""T""----...-~~..---.....~--""T""~--o
2
4
10
12
14
16
6
8
n AVC:

Figure 10:

A C"TC"i:>

'"' I C"l"Tlt'\tJ

Microsomal and nerve ending fraction from DFP

(3.5 mg/kg) treated 20-day old rats at a concentration of 1 mg/ml was homogenized with Triton
X-100 to a final concentration of 1%.

After incu-

bating for 6 hours at 4• C, mixture was centrifuged,
supernatant and sediment were assayed, percent enzyme
activity was determined by calculating the values
of Triton X-100 treated DFP fractions (activity of
Triton X-100 treated sup + sed) against the Triton
X-100 treated similar control fractions.

Each point

in the curve represents the value obtained from 6
rats.

Values are expressed as..:, S.E.M.
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In microsomes on the day of injection the soluble and
total AChE were inhibited 76% and 66% respectively.

Fifteen

days following DFP, the total AChE was found to be inhibited
24% and the soluble AChE to

34%.

On the first day following DFP, the difference in inhibition of the total enzyme as compared to soluble enzyme was
around 10-12% in the case of both microsomal and nerve endings.
This 12% might represent the AChE which is membrane bound and
not accessible to inhibitors or it might represent the membrane bound enzyme which is being newly synthesized.
words,

th~re

by DFP.

In other

was membrane bound AChE which was not inhibited

When this enzyme was released by Triton X-100, it

diluted the inhibited enzyme, consequently, the activity
value for the total enzyme was higher (or inhibition lower)
than that for soluble enzyme.

EFFECT OF TRITON X-100 ON THE DFP-INHIBITED AChE AND CONTROL AChE:
We decided to study the effect of Triton X-100 on the
microsomal and nerve ending AChE of control and DFP-treated
rats at various time intervals.

The effect of Triton X-100 on

the microsomal and nerve ending AChE from the DFP-injected rats
was compared with the effect on the microsomal and nerve ending
AChE of control rats.

Microsomes isolated as described under Methods were obtained from DFP (3.5 mg/kg)-treated and control 20 day old rats
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adjusted to a protein concentration of 1 mg/ml and treated
with 1% Triton X-100.

The difference in amount between the

total enzyme activity and soluble enzyme activity represented the Triton X-100 released AChE or the bound AChE.

It can be seen in figure ll that in the case of microsomes
obtained from control rate, the soluble AChE of control microsomes increased whereas the Triton X-100 released enzyme decreased with the age of the animal.

The specific activity of

the soluble enzyme of control microsomes increased in 15 days
from a specific activity of 0.109 to 0.190 whereas the specific
activity of Triton X-100 released enzyme underwent a change of
0.210 to 0.120 in the same time period.

In the microsomes of

control animal, the increases in soluble enzyme accompanied by
a decrease in Triton X-100 released enzyine at various time interval might reflect the release of the enzyme from the bound
state (following its synthesis) to the soluble enzyme.

In the microsomes of DFP-treated rats, the specific
activity of soluble enzyme increased markedly from 0.0263
to 0.125 for the period of 15 days.

For the same period, the

Triton X-100 released enzyme underwent a small or no change in
specific activity (from 0.09 to 0.080).

It appears that in

DFP-treated rats, there is a faster rate of AChE synthesis
as compared to control rats.

There might exist an equilibrium

between the Triton X-100 released enzyme and the soluble enzyme.

The steady state of specific activity in Triton X-100

released enzyme (AChE) may be due to occurrence of equilibrium

EFFECT OF TRITON X-100 ON MICROSOMAL ACETYL CHOLINESTERASE
AT VARIOUS TIME INTERVALS IN CONTROL AND DFP (3.5 MG I KG) TREATED 20-DAY-OLD RATS
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Injection

Microsomes from control and DFP (3.5 mg/kg) treated
I

20-day old rats at a concentration of 1 mg/ml was

homogenized with Triton X-100 to a final concentration of l°/o.

After. incubation for

6 hours at 4• c,

the mixture was centrifuged at 100,000xg for 1 hour.
The supernatant and sediment {dissolved in 0.5 ml of

1120) was analyzed for AChE activity.

Normal enzyme

activity without the Triton X-100 was the soluble
enzyme.

The difference between the Triton treated

and the soluble enzyme was named as tPe Triton
released.

.I
!
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between the rapid synthesis of enzyme and it's rapid release
into the soluble form.

Nerve endings from DFP (3.5 mg/kg) and control rats
(20 day old) at a protein concentration of 1 mg/ml were
treated with 1% Triton X-100 in a manner similar to that described for microsomes.

The results showed that the a.mount

of soluble and Triton X-100 released enzyme increased both in
cc~trol

and DFP-treated rats.

In control rats, the specific

activity of soluble enzyme of the nerve endings increased
from 0.098 to 0.120 for a period of 15 days (Fig. 12).

The

Triton X-100 released enzyme for the same period underwent a
change in specific activity of 0.110 to 0.18.

In DFP-treated

rats, the specific activity of the soluble enzyme of the nerve
endings increased from 0.04 to 0.10 for a period of 15 days,
whereas Triton X-100 released enzyme underwent a change in
specific activity of 0.07 to 0.18.

The significance of this

increase in Triton X-100 released enzyme is not knovm.
enzyme might act as a reservoir.

This

The main function of AChE

is at the :nerve endings where it hydrolyzes the released AChE.
It seemed appropriate to visualize the existence of a reserve
pool of enzyme which could be used in time.

TURNOVER OF ACETYL CHOLINESTERASE ISOENZYMES:
Microsomal and nerve ending fraction of DFP (3.5 mg/kg)treated and control rats (20 day old) were treated with 1%
Triton X-100.

Supernatant obtained following treatment with
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EFFECT OF TRITON X-100 ON NERVE ENDING ACETYL CHOLINESTERASE
AT VARIOUS TIME INTERVALS IN CONTROL AND DFP ( 3.5 MG I KG)TREATED 20-DAY-OLD RATS
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Conditions were same as described for figure 11
except 1 mg/ml of nerve ending (synaptosome)
preparation was used.
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Triton X-100 was analyzed electrophoretically by polyacrylamide gel electrophoresis.

By densitometric scanning, the

percent contribution of each isoenzyme to total specific
activity was determined in both groups.

From the specific

activity of AChE of the supernatant applied to each gel 1relative specific activity of each isoenzyme was determined.

Per-

cent inhibition of various microsomal isoenzymes of DFP-treated
rats were determined from the relative specific activity of
microsomal isoenzymes of control rats.

Figure 13A shows the

4 isoenzymes of control microsomes and figure 14A shows the

4 isoenzymes of control nerve endings. In microsomes, the
isoenzymes 2 and 4 were prominent and denser, whereas in
nerve endings isoenzymes

4, 3 and l were prominent and

denser.

B, C, D and E in Figure 13 represent the microsomal
isoenzyme pattern of DFP-treated rats on day l, 3, 5 and 15
following the injection.

On the first day after DFP injection,

the inhibition of microsomal isoenzyme
25%,

49%

4, 3, 2 and 1 were 813,

and 0% respectively (Table VIII).

following DFP, the inhibition of isoenzyme
isoenzyme 2 - 25%.

Fifteen days

4 was 36% and of

In the same period, inhibited isoenzyme

3 was completely replaced by newly synthesized AChE.
the period of 15 days,
isoenzyme

During

45, 25 and 24 percent of inhibited

4, 3 and 2 was replaced by newly synthesized enzyme.
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Figure 13:

B

c

E

Treatment of microsomes with Triton were done accord-

ing to the conditions described in Figure 11.
treated supernatant was applied to each gel.
achieved at

D

4•c

4o-50 µg of Triton
Separation was

in Tris-glycine buffer (PH~8.4) at 3ma per tube

for 3 hours as described in Methods.

Incubation and staining

of the gel were performed according to the procedure described
in Methods.
trol rats.

Gel A:

Triton supernatant of microsomes from con-

Gel B:C:D:E:

Triton supernatant of microsomes on

day 1, 3,15 following intracerebral injection of DFP at a dose

of 3.5 mg/kg in 20-day old rats.
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ACETYL CHOLINESTERASE ACTIVITY (%) OF 1% TRITON X-100
EXTRACTED MICROSOMAL ISOENZYME OF DFP (3. 5mg/kg)
TREATED 20 DAY OLD RAT DETERMINED BY DENSITOMETRIC
SCAN AS COMPARED TO TRITON X-100 TREATED CONTROL MICROSOM
From Origin

Band 4

Band 3

Band 2

Band 1

100

Supernatant from
triton treated
microsomes
Day 1

18. 8

75

51

Day 3

33.8

89

54

Day 5

48.3

Day 15

64.2

Table VIII:

59

100

75

Triton treatment of microsomes and electrophoresis
were perfonned according to the conditions described
in Methods.

Relative Specific Activity of each band

was determined from the specific activity of enzyme
applied to each gel.
Percent inhibition of various isoenzymes of the
DFP-treat~d

group were determined from the Relative

Specific Activity of various isoenzym.es of the control group.

114
These values indicate that the microsomal isoenzymes not only
show differential rate of inhibition but also different order
of synthesis.

This might indicate a different turnover rate

for these microsomal isoenzymes.

The inhibition and recovery of nerve ending isoenzymes
were also studied in a manner similar to those of the microsomal
isoenzymes.
endings.
B,

c,

Figure 14, shows the

4

isoenzymes of control nerve

Isoenzyme 4, 3 and 2 ~.,.ere pl','ominent and dense.

Gel

D and E represents the nerve ending isoenzyme pattern

on day 1, 3, 5 and 15 following treatment with DFP.

From the

values of control rats, percent inhibition of the nerve ending
isoenzymes were determined on the day of injection; the isoenzymes 4, 3, 2 and 1 were inhibited 83%, 30%, 4% and 82% respectively (Table IX).

Fifteen days following DFP injection, the

inhibition of the isoenzyme
respectively.

4

and l was 16 and 25 percent,

Inhibited isoenzyme 3 and 2 were completely

replaced by newly synthesized enzyme.

4, 3, 2 and 1 were replaced

The inhibited isoenzymes

to the extent of

67,

30~

percent, respectively, during a period of 15 days.

4 and 57
Here again

the isoenzymes of nerve endings demonstrated different order
of sensitivity to DFP and of the recovery rate indicating a
different turnover rate.
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4

-,

3
2
1

A
Figure 14:
Gel A:

B

c

E

D

Conditions as described in Figure 13.

Triton supernatant of nerve endings

fractions obtained

from control rats •
.Gel B,C,D,E:

Triton supernatant of nerve ending fraction

isolated on days 1,3,5,15 following intracerebral injection
of DFP at a dose of 3.00 mg/kg in 20-day old rat.
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ACETYL CHOLINESTERASE ACTIVITY (%) OF 1% TRITON-X-100
EXTRACTED SYNAPTOSOMAL ISOENZYME OF DFP (3. 5mg/kg)
TREATED 20 DAY OLD RAT DETERMINED BY DENSITOMETRIC
SCAN AS COMPARED TO TRITON.X-100 TREATED CONTROL
Band 4

Band 3

Day 1

17. 0

70

96

18. 2

Day 3

32.1

78

98

38.2

Day 5

52.7

88

100

60.7

Day 15

84.0

110

100

75.4

From Origin

Band 2

Band 1

Supernatant from
triton treated
synaptosomes

Table IX:

Triton treatment of nerve endings and electrophoresis

were performed according to the conditions described in Methods.
Relative Specific Activity of each band was determined from the
specific activity of enzyme applied to each gel.

Percent inhibi-

tion of various isoenzymes of the DFP-treated group were determined from the relative Specific Activity of various isoenzymes
of the control group,
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DISCUSSION:

EFFECT OF DFP ON RAT BRAIN AC.hE

After attempting various methods of isolation of synaptosomes and analyzing the fractions by electron microscopy, we
chose the method of Autilio and Appel

(1968) as the fractions

obtained by this method were relatively intact.

Synaptosomes

are difficult to obtain as intact preparations due to various
conta..'llinating membranous elements (from various organelles in
nerve cells).

As can be seen from the electron micrographs

(Fig. 1, 2) we were able to obtain relatively intact
tions.

p~epara

Indeed, even the f'unctional contacts between the pre-

and post-synaptic terminal can be seen, as are the intraterminal mitochondria.

Synaptosomes are heterogeneous with respect to chemical
composition.

Synaptosomes derived from the whole brain or

from cerebral hemisphere contain various transmitters and enzymes responsible for their synthesis and degradation.

Synap-

tosomes contain relatively large number of enzymes; enzymes of
the intra-terminal mitochondria, enzymes

of the soluble cyto-

plasm and enzymes of the extra-synaptic membrane.

It is diffi-

cult to assess for contamination as there are no ·specific markers
for synaptosomes.

Since our purpose was to study the protein

synthesis in synaptosomes, we were concerned only with components
which would complicate interpretation of the origin· of protein
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synthesis.

The only contaminating fraction with which we

were concerned were microsomes.

Assaying for NADPH-dependent

cytochrome C reductase in the synaptosomal and microsomal
fraction through various isolation procedures is indicative
of the degree of microsomal contamination.
was found to be less than 15.Q%.

By

The contamination

using rotenone in the

assay medium, we eliminated the results arising from the mitochondrial enzyme. (Table X).

We noted a low recovery of radioactivity in earlier ex.periments using (c14)DFP.

The radioactivity of the homogenate
following injection with (c14)DFP increased with increasing

amounts of (c 14 )DFP but the recovery was still low.

The

original compound (c1 4)DFP was in propylene glycol.

Since

propylene glycol is an inert solvent, various media were tested
to improve the binding of (c1 4)DFP to the brain.
seen (Table 2), there was no

As can ·be

improvement in the recovery of

the counts when various media were employed.

The low recovery

of counts in various subcellular fractions indicated loss of
radioactive counts following the injection.

Jandorf and McNamara (1950) injecting(3 2P) labelled DFP
intravenously into rabbits found that radio phosphorus was retained in relatively large amounts by kidney, liver and lung,
while brain and other organs retained very insignificant amount
of label.

The brain, while exhibiting high levels AChE had
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TABLE X

NADPH CYTOCHROME C REDUCTASE ACTIVITY OF MICROSOMAL AND
SYNAPTOSOMAL FRACTIONS.

SPECIFIC ACTIVITY IS EXPRESSED AS

..GI!: 550/minute per mg of protein

Microsomal Fraction

0.255

0.26o

0.250

0.250

Synaptosomal Fraction

0.025

0.028

0.030

0.030
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the least amount of radioactivity.

Cohen and Warringa

(1954)

studying the fate of DFP in human body found that its metabolism involved both protein binding and detoxification, about
80% of (3 2P) was excreted in urine as diisopropyl phosphoric
acid and about 20% remained bound to the tissue.

DFP bound

nonspecifically to tissue proteins show little dealkylation
compared to DFP which was found to brain enzymes.

DFP bound

nonspecifically to tissue proteins was hydrolyzed after a few
hours.

14

During injections with (C

)DFP, in one set of experi-

ments, we found large amount of radioactive counts
(Table 1).

in liver

The liver radioactive counts may represent DFP

lost in detoxification and in the course of nonspecific binding.

Normally aging phenomenon following DFP occurs by the

loss of one isopropyl group.

In a uniformly labelled (c14 )DFP,

the aging phenomenon would result in a loss of
jected label.

503 of

the in-

There may be further loss of label due to" non-

specific binding of (c14 )DFP to tissue proteins.

The actual

counts obtained by us might represent the label bound to acetyl
cholinesterase.

These may be the reasons for the low recovery

of counts obtained.

The low recovery of counts did not permit

the determination of the binding of inhibitor to :ndividual
isoenzymes.
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In our later experiments, using unlabelled DFP, a minimum

of 2.0 mg/kg of DFP was required by intracerebral injections to
inhibit 92% rat brain AChE (in 16 day old rats).
inhibition with rat brain homogenate in vitro,
92% inhibition of AChE.

Studying the
10-~ DFP caused

In terms of concentration at least

seven times the in vitro concentration of DFP was required

.!!'.!

vivo to inhibit the enzyme to the same extent.

In a homogenate, the structures of the organelle may be
ruptured resulting in a better reaction with the inhibitor.
On the other hand, in an in vivo system, (intact system), higher
a.mount of inhibitor will be required to reach the enzyme bound
to the membranes (synaptic junction).

Once the inhibitor binds

the enzyme, the binding becomes irreversible.

Before it reaches

the enzyme, it might bind nonspecifically to tissue proteins and
proteolipids or might be carried in the blood stream away from
the injected organ for the purpose of detoxification.

Another explanation for the requirement of high dose
in vivo is related to the hydrolysis of the DFP by certain
enzymes present in the system.

Mazur (1946) observed that

l0- 2M DFP in the presence of serum produced a considerable
C~

evolution from

~

bicarbonate medium and that similar

results could be obtained with tissue extracts and found this
is due to DFP hydrolyzing enzyme.

Aldridge also reported the

hydrolysis of paraoxan (E-6oo) by serum esterase.

The high

,
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a.mount of

nonsp~cific

esterase, especially aryl esterase pre-

sent in the brain might hydrolyze injected DFP.

PROTEIN SYNTHESIS AND AXOPLAS.MIC TRANSPORT:
There are a number of indications from our studies and
that of others that nerve endings can synthesize their own
protein.

The classic studies of Weiss

(1943, 1947, 1959, 1967)

have sho1m that a mass of neuroplasm material migrates down
the axon at a rate of approximately 1 mm per day.

Weiss

proposed the concept of axonal flow as a mechanism for the
transport of speciailized cell products from the central site
of manufacture to peripheral destination.

Lasek

(1968) using

autoradiographic and scintillation counting technique studied
the distribution of 3ir-leucine injected into the cat dorsal
root ganglion and ventral horn region of the rat spinal cord.
Bates of axoplasmic transport up to lOOmm per day were found
in the case of the motor neuron and of the dorsal root ganglion
cells of the cat, respectively.

Lasek proposed that two cate-

gories of axoplasm.ic transport may be distinguished, in one
case, the materials mostly protein is transported from the
cell body at a few millimeters per day, as observed by Weiss
and his co-workers; in the other, the protein is transported
~Tith

a wide range of only a few millimeters up to 100 to 500 mm

per day.

Various theories have been proposed regarding the
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mechanism of axoplasmic flow.
by experimental data.

None of them is finnly supported

Weiss (1967) and Ochs (1963) proposed

that axoplasmic transport

occurs by peristalic movement and

energy is obtained from periaxonal elements.

Recent tissue

culture suggests the presence of a protein which by change in
configuration provide the necessary energy for transport.
Borisky and Taylor (1967) found a protein associated with
microtubules and filaments in mammalian brain and squid
axoplasm which had a high affinity for colchicine.
of this protein in transport is being considered.

The role
A survey

of concentration of this protein in a variety of cell types
showed that protein extracts and specifically the extracts
of axoplasm were the richest source of colchicine binding
protein which is presumed to be subunit of microtubules.
(Shelanski and Taylor, 1970).

It is a major soluble protein

and may also exist in particulate form.
protein was shovm to be about 4 days.

Half life of this
Therefore microtubules

are influx rather than structural elements.

It has been

shown that this protein migrates with a slow component of
axoplasmic transport.

Although nerve endings do not charac-

teristically contain any identifiable microtubules, substantial proportion of soluble component of isolated nerve ending
fraction is microtubular protein.

r
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Studying the axonal transport of cholinergic enzymes,
(Fonnum et al, 1973) the estimated-rate for AChE was 430mm/24
hours for vagus and 73mm/24 hours for the bypoglossal nerves.
These rates correspond to the fast or intermediate rate of
axonal flow.

They also found that only small proportion of

the enzymes (5-20%) were mobile and concluded that only a
part of AChE in the vagus and hypoglossal nerve migrated.

A

retrograde transport of the enzyme was also demonstrated.
The amount of enzyme transported this way, represented only a
small portion of the total transport of cholinergic enzymes.

If it was assumed that AChE was transported by a fast
transport, there must exist a mechanism by which it is transported to the presynaptic membrane.

Tubular protein which

was considered to be involved in transport was found to
migrate only with slow component of axoplasmic transport.
Furthermore, nerve endings do not characteristically contain
any identifiable microtubules.

Fonnum et al (1973) found only

a small percent of the enzyme being transported and retrograde
transport was much lower than this.

So there must exist a

system for breaking down the enzyme at nerve endings.

Lyso-

somes have not been shown to be present in the nerve ending
fraction.

A small amount of proteinase activity with a PH

range of 5.3 to 6.9 was found at NE (Palladin and Belik, 1970);
Whether the proteinase is responsible for the breakdown of
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AChE in the nerve ending is not known.

As the main function

of AChE is at nerve ending, a higher percent of the enzyme
should be expected to be transported if it was dependent on
the cell body for its synthesis.
found to be stationary.

Large amount of enzyme was

Axoplasmic transport of AChE still

remains an open question.

On

the other hand, there is evidence for local synthesis

of protein in the nerve axon as shown in vivo and
studies.

E!

vitro

T'ne recent extensive work with the unicellular

organism Acetabularia (Bracket, 1967) constituted an important
stimulus to consider the possibility that protein may be
synthesized at sites which are very distant from cell nucleus.
There is evidence that axon can survive for a considerable
period of time after its transection from the cell body and
can synthesize ribonucleic acid and protein particularly in
chloroblasts.

Protein synthesis in isolated synaptosomes have been shown
by various workers as discussed earlier (cf. Introduction;
Autilio and Appel, 1968; Austin and Morgan, 1967 and Goldberg,

1971). The lack of visible ribosomes in both the axon and its
endings does not I"lle out the possibility of protein synthesis
in such tissues, since RNA with base ratios consistent with
ribosomal RNA has been found in Mauthner axons of fish

r
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(Edstrom et al., 1962) and in cranial nerve roots in cat
(Koenig, 1965).

RNA is present in synaptosomes in particular

in the non-mitochondrial membrane deprived from these synaptic
organelles (Austin and Morgan, 1967).

Studying protein syn-

thesis in vitro synaptosomal preparation, Austin and Morgan
(1967) showed that uptake of radioactive amino acid was
linear for an hour.

The synaptosomal fraction was broken down

to its components by osmotic shock.

Membranes, soluble pro-

tein and mitochondria derived from osmotically shocked synaptosomes were all labelled with amino acid showing the most
rapid rate of labelling.

Their results stongly suggested that

synaptosomes can synthesize protein and since not only mitochondria but also synaptosomal membranes and soluble protein
were labelled, it seemed possible that a protein synthetic
machinery exists either in the membrane or the cytoplasm of
nerve ending.

Various workers used protein synthesis inhibi-

tors to differentiate the biosynthesis of proteins in the
synaptosomes and in particular to determine whether the synthesis is of synaptosomal or mitochondrial type.

It could be

argued that the amino acid incorporation is not into synaptosome at all, but is merely the result of an uptake by some
contaminants such as bacteria, mitochondria or ribosomes.
Autilio et al.(1968) showed that bacteria isolated from the
incubation mixture incorporated leucine linearly for at least
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5 hours, whereas the rate of incorporation into synaptosomal
protein fell off rapidly after 20-30 minutes.

These bacteria

were very sensitive to chloramphenicol inhibition, whereas the
synaptosomes are not.

Mitochondria from brain synthesize pro-

tein (Campbell et al., 1966, Bachelard, 1966) but despite the
inclusion of mitochondria within the nerve ending, all of the
protein synthesis cannot be due to mitochondria.

The sensi-

tivity of mitochondrial protein synthesis to chloramphenicol
.

.

has been demonstrated for mitochondria from a wide range of
tissue including brain (Kroon, 1963, Clark-Walker and Linnane,

1967) and yet synaptosomal protein synthesis was inhibited by
only 25%, a figure which suggests contribution made to the
system by both synaptosomal and contaminating mitochondria
(Austin and Morgan, 1967).

Mitochondria derived from synapto-

some showed less than 2% of the incorporated isotope in a solubie fraction isolated after sonication (Autilio et al., 1968).
The soluble protein isolated from synaptosome after incubation
with leucine had about 20% of the total incorporated label.

Contamination by free ribosomes released from other structures is not a problem in this system.

Brain ribosomal system

is inhibited almost completely by incubation with ribonuclease,
but the intact synaptosomal system is unaffected (Campbell et al.,

1966). When labelled microsomes added to a brain homogenate
did not contaminate the synaptosomal fraction which was
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subsequently isolated from the homogenate (Austin and Morgan,

The origin of axonal RNA is unknown.

It could be trans-

ported from the cell body or from Schwann cells or glia along
the axon.

It does seem however that the nerve receives the

RNA or RNA precursor in some way by transport along the nerve
rather by direct uptake fro111 the blood.

Our study was undertaken to study the mechanism by which

AChE is formed at the external membrane of the pre- and postsynaptic terminal and the junctional complex.

The question

was whether it is formed locally or was transported from the
cell body.

AChE is associated chiefly with membranous struc-

tures in rat brain (Toschi,

1959). At the synaptic area, it

has been shown to be localized on the external membrane of the
presynaptic terminal and in the junctional complex.

The hypo-

thesis on the functional significance of AChE is based in part
on their known localization.

The membrane-bound enzyme has

implications for function which are different than those for the
function at the cytoplasmic-localized enzyme and the hypothesis
of the functional AChE and the related hypothesis of Koelle

{1961) are based on the identification of functional AChE at
the synaptic membranes.

!
I
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We studied the synthesis of AChE in the 20-day old rat
following DFP injections (3.5

mg/kg).

nerve endings synthesized or replaced

For a period of 15 days

47% of the inhibited AChE,

while rnicrosomes replaced 42% of the inhibited enzyme.

Since

this period represents a period of rapid growth in the animal,
attempts were made to differentiate the enzyme arising due to
normal growth and those arising due to enzyme replacement af'ter
DFP inhibition.

After the appropriate corrections, it was f'ound

that AChE synthesized to
to

43%

replac~

the DFP inhibited enzyme a.mounted

a~ the nerve endings and to

16% at the rnicrosomes.

The ability of' synaptosomes to incorporate (c14 ) leucine
into their proteins was found to decrease with the age of the rat
{Austin and Morgan,

1967). However our data indicate the pre-

.sence of a AChE synthesizing :machinery at the nerve endings of
· older (58 days older) as well as of younger animals (20 days
old).

In 58 day old rats following DFP injections (2.0 mg/kg),

ther nerve endings synthesized and replaced
AChE, while microsomes replaced

45% of the inhibited enzyme.

According to some investigators {Weiss
proteins are

presu.~ed

64% of the inhibited

and Hiscoe,

1948)

to be transported to nerve endings from

the cell body following its synthesis at rnicroson ..;s.

If nerve

ending AChE had its origin in the cell body and was transported
from the rnicrosomes at the cell body, a faster rate of micro-
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somal AChE synthesis compared to its appearance at nerve
endings could be expected following DFP administration.
There would be a time lag, if replacement is dependent on
microsomal synthesis for the enzyme and its subsequent transport from microsomes to nerve endings.

Altogether it would

take time for AChE to be transported from the cell body to
the nerve endings.

Since AChE is a protein of high molecular

weight, it would probably be transported by a slow process.
we.never found a time lag in nerve endings either in 20 day
or 58 day old rats, in fact recovery data indicate an earlier
onset of AChE synthesis.

This evidence indicates that the

synthesis of AChE may occur in the nerve endings.

The

higher rate of synthesis of AChE in nerve endings as compared to the microsome of older animal following DFP might
be due to higher initial inhibition of AChE which occured in
these animals.

Our 'results throw a light on the paradox of

coexistence of free cytoplasmic acetyl choline and acetylcholinesterase in the same cell which is conconnnitant with
the concept of the axoplasmic transport.

As the nerve ending

fraction synthesized their ovm AChE at the membrane, there will
not be a need to supply the enzyme from the cell body and there
would be no cytoplasmic enzyme capable of AChE hydrolysis.

PROPERTIES OF THE MEMBRANE BOUND AChE:
Several enzymes have been extracted from the membranes
and their properties were found to be different from those of
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the naturally-bound enzymes.
allotopy (Racker, 1967).

This phenomenon has been termed

The first example of allotopy to be

described was that of mitochondrial ATPase (Fl) (Racker, 1967).
In its membrane-bound form, the enzyme was sensitive to oligomycin and

I~.I\f.

dicyclohexyl carbodiimide; in the soluble form

this sensitivity was lost but the enzyme became cold labile.
Solubilizing the succinic dehydrogenase from the irmer membrane
of mitochondria, various workers found modifications of properties of the enzyme.

The catalytic properties of the membrane-

bound enzyme was found to be different from the soluble dehydrogenase (Cerletti et al., 1967).
TTA (2 Thionyl Trifluoreacetone,

The iron chelating agent

4,4,4,4 Trifluoro-1-(2-thionyl)

1-3 butane dione) was found to inhibit only the membrane..:bound
enzyme at low concentrations (Redfearn, 1965).

The membrane-

bound dehydrogenase was found to be more stable than the solubilized one (King, 1963).

Other enzymes have also been shown

to exhibit this phenomenon of allotopy.

THE PROPERTIES OF THE MEMBRANE-BOUND ENZYME are different due
to the difference in their surroundings.

The properties may

be influenced by 1) the general chemical and physical nature
of the membrane, 2) by specific interactions of the enzyme
with various molecules in its immediate neighborhood and

3) by local effect of the enzyme and that of its neighbors.
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We decided to solubilize the membrane-bound enzyme and
study the difference in property between the soluble enzyme
and the membrane-bound enzyme.

Initially as a model system,

we studied the effect of Triton X-100 on the human brain AChE.

We found considerable activation of the enzyme with
Triton X-100 (Table

6).

13

Other workers also found activation

of AChE with Triton X-100..

Harwood and Hawthorne (1969) found

considerable stimulation of ACbE with.Triton X-100 (cf. also
Crone, 1971).

Fiszer and De Robertis (1967) claimed only

solubilization of the enzyme with Triton X-100 though their
Triton X-100 treated mitochondrial fraction showed an increase
in activity.

In the case of the human brain, we found an increase in
AChE activity in the supernatant with Triton X-100, without
concomitant change in the activity of the sediment.

The analy-

tical data indicate that the increase in acetylcholinesterase
activity that is demonstrable with the use of Triton X-100
in the extractive media is not due to more complete extraction of the enzyme from the particulate to which it is bound
but to changes in the properties of the catalytic protein.
This is evidenced by change

in supernatant

acti\~ty

without

any connnensurate changes in the activity of the residue.

These

changes could be due to the catalytic protein released from
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association with membrane fragments; as originally associated
with the membrane, AChE may have been not fully active.

The

nature of the binding of enzyme to membrane could be altered.
This can lead to either the unmasking of hidden catalytic
sites by release of an allosteric inhibitory mechanism or by
conformational changes in the molecule due to rupture of lipophilic bonds.

It appears that Triton X-100 alters the conforma-

tion of the enziroe resulting in an enhancement of catalytic
activity.

The effect of Triton X-100 on the AChE activity of subcellular fractions of DFP (3.5 mg/kg)-treated 20-day old rats
was also studied.

The Triton X-100 treated microsomal and

synaptosomal fraction displayed a lower percent of AChE inhibition following DFP as compared to buffer treated fractions.
The difference in inhibition between the Triton X-100 treated
enzyme and the soluble enzyme was around 10-12% in the case of
microsomes and nerve endings.

This fraction might represent a

pool of reserve enzyme or the membrane-bound enzyme which is
not accessible to DFP.

It is also possible that Triton X-100

treatment opens active sites which are not normally available
for interaction with substrates or it might represent the
newly synthesized enzymes _which are not available to substrates
normally.
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Effect of Triton X-100 on nerve ending microsomal AChE
of control and DFP-treated rats at various intervals of time
in 20 day old rats (age 20-35 days).

In the case of microsomes

(Fig. 11), the specific activity of the enzyme released by
Triton X-100 decreased with the age of the animal, while the
specific activity of the soluble enzyme increased with age.
In the DFP-treated group, the soluble enzyme increased, .while
the enzyme released by Triton X-100 remained almost constant
during aging.

This situation was markedly different in the

nerve ending fraction (Figure 12) as in this case the soluble
as well as Triton-released enzyme increased both in control as
well as DFP treated animals.

The large increase in Triton-

released enzyme found in nerve endings at various ages may
represent a reserve or a pool enzyme.

In microsomes only the

soluble enzyme increased at various ages whereas the Triton
released enzyme decreased during the various time intervals.

The main physiological function of AChE is at the nerve
endings.

It is possible to have a pool of enzyme acting as

a reservoir at nerve endings.

The increase in Triton releas-

able enzyme at nerve ending following DFP was not accompanied
by a similar increase or decrease at the microsomal enzyme level.
This further indicates that the nerve endings possess an independent protein synthesizing machinery of nerve endings.

The

ability of the nerve endings to synthesize the soluble as well
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as the membrane-bound enzyme is clearly shown.

We excluded by appropriate tests the possibility that
our results were related to microsomal contamination of the
synaptosomes (cf. Table X).

If the nerve endings were con-

taminated with microsomes, the enzyme recovery would follow
a pattern similar to microsomes.

The absence of such pattern

diminishes the possibility of the results arising from rr.icrosomal contamination.

As the

p~rcent·of

enzyme activity was

calculated against the values from control rats, the minimal
error which may arise from microsomal contamination is eliminated to a large extent.

ISOENZYMES OF ACETYLCHOLINESTERASE
We have resolved several bands with AChE activity in
rat brain tissue by polyacryla.mide gel electrophoresis.

Since

the soluble extract gave a similar pattern in the case of the
microsomes and of the nerve endings, we used a 1% Triton X-100
extract which showed differences in isoenzyme pattern of nerve
ending and microsomes.

As 1% Triton produced consistent re-

sults, it was used in this experiment.

Five hours after DFP

injection (3.5 mg/kg), microsomal isoenzymes extracted by 1%
Triton X-100 showed differential inhibition patterns (Fig. 13).
A~er

analyzing the results by a densitometer, the order of

inhibition of the

4 microsomal isoenzymes on the day of injec-
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tion was 82,

49,

spectively.

The rate at which these isoenzymes were replaced

25 and o<1/o for isoenzymes

4,

2,

3 and

by newly synthesized enzyme was also different (Table

1 re-

8).

The nerve ending isoenzymes underwent a different order
of inhibition and recovery as compared to microsomal isoenzymes.
On the day of injection, order of inhibition of the isoenzymes

of nerve endings was as follows:
1 (72%), Isoenzyme

3 (30%),

Isoenzyme

Isoenzyme 2

4 (83%),

(4%).

Isoenzyme

In a period of

15 days, the inhibition of isoenzyme 4 was reduced to 16% and
isoenzyme 1 to 25%.

The other two isoenzymes were completely

replaced by newly synthesized enzyme.

Again, the recovery of

nerve ending isoenzyme were different from that of microsomal
isoenzymes.

If the two subcellular fractions, namely micro-

somes and nerve endings exhibited similar pattern of inhibition and recovery, then the question of contamination of microsomes in nerve ending arises.

Furthermore, comparing the

differences between the inhibition and recovery of microsomal
and nerve ending isoenzyme confirms the notion of independent
synthesis of AChE in the nerve endings.

On the day of injection,·

the inhibition on microsomal isoenzyme 1 was zero, but the nerve
ending isoenzyme 1 was inhibited 82%.

Isoenzyme 2 was on the

way to recovery in microsomes, whereas at nerve endings it was
completely replaced by newly synthesized enzyme for the same
period.

Isoenzyme 4 which seems to be a dominant one in both

f
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subcellular fractions, was synthesized to
endings and to
with DFP.

67%

at the nerve

45% at the microsomes following inhibition

These data again indicate the independent protein

synthesizing machinery at the nerve ending.

Microsomal and nerve ending isoenzyme pattern were
reproduced following various freezing and thawing procedures.
This indicates that they are separate units and are not formed
by recombination of subunits.

If the nerve ending isoenzymes

were supplied by the microsomes by axoplasmic transport, then
the order of inhibition with DFP and resynthesis would follow
the same pattern.

The two sets of isoenzymes (microsomal and

nerve ending) follow entirely a different course following
their inhibition with DFP.

These results further support

the presence of an independent protein synthesizing machinery
at the nerve endings which is also responsible for the synthesis
of isoenzymes.

Davies and Agranoff (1968) in three different

kinds of experiments have demonstrated' that there is an isoenzyme of rat retina with an unusual half life of about 3 hours.
Studies with several enzymes have indicated that these proteins
are synthesized with a zero order reaction rate and degraded
randomly with a first order rate (Rechagl and Weston, 1967).

In our preparations, isoenzyme 4 from nerve ending had a
half life of 11 days while the microsomal isoenzyme 4 had a
half life of 16 days.

Rest of the isoenzymes at the micro-
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somes and nerve ending exhibited half lives ranging from 11 to
50 days.

The significance of this difference in the turnover

rate of these isoenzymes is uncertain.

The isoenzyme with a

fast turnover rate may act as a precursor to other isoenzymes.
These isoenzymes may have a different physiological role.

In

the case of nerve endings, the rapidly recovering isoenzyme
might represent the functional enzyme responsible for the
transmitter hydrolysis.
have different roles.
other enzymes.

The other three isoenzymes might
They may act as a precursor to the

In microsomes, a different set of conditions

may exist.

(1974) also confirmed the existence

Wenthold et al.,

of multiple active forms of rat brain acetylcholinesterase and
ob~erved

six forms by electrofocusing the enzyme.

The six

forms separated by electrofocusing were similar in several
respects.

They found

~hem

to be glyco-protein containing a

subunit of same molecular weight with a distinct, reproducible isoelectric point.

Specific isoenzymes were found to be

concentrated in different subcellular locations.

Similar to

our results, they also noted the existence of enzyme in soluble
and membrane-bound forms and the differences in the enzymes
from these two different origin were also seen.

On treating

the isoenzymes with neuraminidase, they did not find any alteration in the isoelectric pattern.

r
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Studying AChE isoenzymes in mouse brain, Kahayashi et al.,

1973, found three different isoenzymes differing in PH optima,
Km and inhibitory properties.

The three isoenzymes were found

to be distributed in different subcellular fractions.

They

proposed different physiological f\lnction for these isoenzymes.
The heterogenity of the rat brain synaptosomal AChE has been
shown electrophoretically by Glebov et al., (1970).

Using a

different extraction medium, they found differences in number
of AChE bands in synaptosomes and in mitochondria (Glebov et al.,
1971).

The physiological function of the isoenzymes remains to

be determined, but it seems likely that they correlated to the
different subcellular localization of the enzyme.

In the case

of the choline acetyltransferase, Fonnum and Malthe Sorenssen

(1973) sought to correlate a higher isoelectric point and
·higher positive charge with enhanced tendency to bond to
negatively charged residues in membranes.

So far the charge

distribution among the different forms of AChE does not correlate in any obvious way with electrostatic binding properties
of the membranes.

Probably when more is known about structure

of neuronal membranes, light will be thrown regarding the
localization of these AChE isoenzymes to the membrane surface.
The isoenzymic forms though catalyzing the same reaction do
generally have distinct catalytic properties which presumably
enables each of them to function in accord with physiological
requirements either at different sites within the cell or in
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distinct metabolic sequences {Stadtman, 1968).

The most

important biological question posed by isoenzyme is simply
their existence.

They must clearly confer great advantages

to an organism, else they would not be so common.

But just

what each isoenzyme does that distinguishes it from others
is still largely unknown.
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CONCLUSIONS AND SUMMARY
The protein requirement of synapses poses a unique
problem as they are located at some distance from the cell body.
The macromolecular requirement of synapses is a problem by
itself in normal state as well as in pathological conditions.
The question arises as to whether synapses synthesize all
their proteins or do they depend on the cell body for proteins.
As a model to study such a mechanism, we chose a system of
isolated synaptosomes and microsomes from 20 and 58 day rat
brain previously injected with DFP and studied specifically
the synthesis of AChE.

47%

In 20-day old rats, following DFP,

of the inhibited AChE was synthesized at nerve endings,

while for the same period 42% of the inhibited enzyme was
synthesized at microsomes.

Since 'the period represents a

period of rapid growth in the animal, attempts were made to
differentiate the enzyme arising due to normal growth and those
arising due to enzyme replacement after DFP inhibition.

After

the appropriate corrections, it was found that AChE synthesized
to replace the DFP inhibited enzyme amounted to 43% at the
nerve endings and to 16% at the microsomes.

In 58 day old

rats, 64% of the inhibited nerve ending AChE was synthesized
and for the same period microsomes synthesized 45% of the
inhibited enzyme.

This phenomenon was not an age dependent

one as it was found in both age groups.

AChE was found to

r
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be synthesized at nerve endings without a concomittant increase
or decrease of microsomal enzyme which suggested an independent
synthesizing machinery of nerve endings.

When Triton X-100

was used to solubilize AChE, the inhibition due to DFP

~ras

considerably less in nerve terminals and microsomes compared
to DFP inhibition measured in buffer treated fractions.

These

results suggest that a reservoir of the enzyme is not available
tc substrate and to inhibitors such as DFP.

We also found differences in the rate of inhibition and
recovery of isoenzymes in the microsomal and nerve ending
fraction following DFP which f'urther confirmed the independent
synthesizing machinery of the nerve endings.

On

the day of

injection, the order of inhibition of the 4 microsomal isoenzymes was 81,

49, 25 and oo/o for isoenzymes 4, 3, 2, 1.

Fifteen days following DFP, the inhibition of isoenzyme· 4
was

3&/o

and isoenzyme 2 was 25%.

In the same period, inhibited

isoenzyme 3 was completely replaced by newly synthesized AChE.
The inhibition and recovery of nerve ending isoenzyme were
also studied in a manner similar to those of the microsomal
isoenzymes.

On the day of injection, the isoenzymes

and 1 were inhibiter. 83, 30, 4 and 82% respectively.

4, 3, 2
Fifteen

days following DFP injection, the inhibition of isoenzyme 4
and 1 was 16 and 25 percent respectively.

Inhibited isoenzyme

r
143
3 and 2 were completely replaced by newly synthesized enzyme.
The isoenzymes of nerve ending demonstrated different order of
sensitivity to DFP and of the recovery rate indicating a
different turnover rate.

Certain hypothesis were made regarding the f'unction of
these isoenzymes.

Microsomes might supply the enzyme around

the cell body which prevents the proliferation of Ach into
cell from other sources.

Nerve endings might supply the

enzyme at the junctional complex whose main role is to
.hydrolyze the transmitter following chemical transmission.
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